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Formate is an important intermediate in a number of metabolic reactions. Most of the 
formate pool in cells is generated from the degradation of primary metabolites (glucose, 
pyruvate, amino acids) and further degraded into CO2 and CH4. Remaining formate is 
recycled and utilized in one-carbon metabolism where a one-carbon formyl group is 
integrated into nucleotide metabolism, protein synthesis, and generation of secondary 
metabolites such as siderophores. Here I provide two examples of distinct and unique 
enzymes involved in formate generation and metabolism: PvdF from Pseudomonas 
aeruginosa and RibB from Vibrio Cholerae.   
PvdF is one of two enzymes involved in generation of the formyl-hydroxyornithine 
(fOHOrn) moiety responsible for iron chelation in pyoverdin, a siderophore in 
Pseudomonas aeruginosa. Biochemical and structural studies suggest that PvdF is a 
unique new class of transformylase enzyme. PvdF catalyzes the movement of the formyl 
group from an N10 formyl-THF analogue to the substrate following the bireactant random 
substrate binding model. Structurally, PvdF has a transformylase fold with secondary 
structural element insertion so far unprecedented in the literature.  
RibB is involved in the biosynthesis of riboflavin, vitamin B2. This is a magnesium 
dependent enzyme that catalyzes the conversion of the sugar ribulose 5-phosphate 
(Ru5P), a product of the pentose phosphate pathway, into 3,4-dihydroxy-2-butanone 4-
phosphate (DHBP). The reaction catalyzed by RibB is an unusual deformylation reaction 
in which the fourth carbon of the five-carbon sugar is removed as formate. According to 
the literature, RibB catalyzes this reaction in the presence of di-metal Mg2+ centers 
following 1,2-methyl shift, called a skeletal rearrangement mechanism. Our evidence, 
 iv 
both biochemical and structural, suggests that RibB requires only one Mg2+ for catalysis. 
Furthermore, NMR and X-ray crystallography data point toward the formation of a 2-
phosphoglycolic acid intermediate during RibB catalyzed reaction. These data suggest 
that a fragmentation mechanism, not a skeletal rearrangement, is the preferred 
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Structurally formate is one of the simplest carboxylate anions in the cell. This molecule 
is directly or indirectly involved in number of metabolic reactions [1-3]. For example, in 
one-carbon metabolism, formate is incorporated with tetrahydrofolate (THF) cofactors 
and further integrated into purine metabolism, used in iron chelation (siderophore 
biosynthesis) or as a recognition tool for first amino acids (fMet-tRNA) of protein 
biosynthesis. Current research on formate anabolic and catabolic reactions is extensive. 
How this molecule is going to be utilized will depend on bacterial extracellular 
environmental conditions [2, 4]. What has been proposed is that biggest proportion of 
generated formate is made during anaerobic degradation of carbohydrates such as 
glucose. Product of the degradation, pyruvate, is converted to formate by pyruvate 
formate lyase to make acetyl-CoA and formate. Formate is also made as the end 
product of degradation of amino acids (serine, glycine, threonine, histidine) as well as 
biproduct in generation of metabolites (such as riboflavin, formyl Met tRNA) [1, 5-7]. 
From the cellular formate pool this anion can either be reused, further oxidized into 
carbon dioxide or reduced into methane. For example, in purine metabolism of aerobic 
bacteria, when the essential cofactor N10-formyl THF cannot be made, a purine 
intermediate can still be generated using intercellular formate and ATP. This has been 
demonstrated to be an alternative mechanism that would allow for bacterial growth and 
nucleotide generation even in the absence of essential (THF) cofactors [8, 9]. Formate 
is oxidized to carbon dioxide and hydrogen by formate dehydrogenase. These 
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dehydrogenases are complex and have been reported to be either NAD+ dependent or 
NAD+ independent. The NAD+ independent reaction generates CO2 in the presence of 
ferrocytochrome b1 and an iron sulfur cluster. Electrons generated during this process 
have been shown to contribute to bacterial respiration (proton motive force) as well as 
nitrate reduction.  NAD+ dependent reaction catalyzes the generation of CO2 in typical 
NAD+ dehydrogenase manner, by reduction of NAD+ into NADH [2, 4, 10-12]. These 
enzymes have been studied extensively, they do not require metals and are usually not 
membrane bound. On the other hand, conversion of formate to methane is rare and the 
perfomed by class of organisms called methanogens. Methanogens are archaeal 
organisms that depend on simple carbon molecules such as carbon dioxide, formate, 
acetate and methanol. In short, in order for these organisms to survive they need to live 
in a proximity to bacteria, organisms that are able to convert complex molecules into 
their vital metabolites. Conversion of formate to methane is complex and it involves 
multiple enzymatic steps and presence of a pterin cofactor as well as F420 cofactors [2, 
13]. 
The focus of this dissertation will be two examples of formate utilization. One is PvdF 
enzyme from Pseudomonas aeruginosa. This enzyme is crucial in pyoverdin 
biosynthesis using N10-formyl-THF as a cofactor. The other is in riboflavin biosynthesis 
where enzyme RibB releases formate after conversion of ribulose 5-phosphate into 





1.1 Role of formate in one-carbon metabolism.  
One-carbon metabolism is the transfer of one-carbon groups such as methyl groups on 
folate cofactor to make S-adenosylmethionine.  Herein, we will consider the transfer of 
one-carbon groups attached to folate, which is central to biosynthetic pathways involved 
in the formation of purine nucleotides and amino acids such as glycine, serine and 
methionine[14, 15]. Cancer cells require both a constant supply of nucleotides and a 
mechanism for the regulation of gene expression by methylation [16, 17]. Inhibition of 
enzymes in one-carbon metabolism provides an avenue to design antifolate inhibitors 
that are effective against cancer cell proliferation. Enzyme-specific inhibitors that are 
folate mimics have been developed that target dihydrofolate reductase [18, 19] and 
thymidylate synthase [20, 21], among others [22-28]. Some of these inhibitors, such as 
methotrexate, are also effective against other diseases such as arthritis and psoriasis 
[29, 30].   Indeed, many antifolate inhibitors are nonspecific [31].    
Folates are comprised of three parts: a pterin ring (made from GTP), a p-aminobenzoic 
acid (pABP, derived from chorismate) and a glutamate tail [15].  Whereas enzymes for 
the biosynthesis of the folate core can be found in lower eukaryotes, protozoa, bacteria 
and plants [32, 33], mammals do not have genes for folate synthesis and must obtain 
folic acid, vitamin B1, from their diet. For this reason, one-carbon metabolism is also a 
target for the synthesis of antibacterial and anti-parasitic compounds. One of these 







Figure 1.1. One carbon metabolism and utilization of N10-formyl-THF in bacteria. Folate 
cofactors are indicated in bold letters. DHF stands for dihydrofolate, THF for tetrahydrofolate. 
Enzymes involved in one carbon metabolism designated as: DHFR (dihydrofolate reductase), 
MS (methionine synthase), MTHFR (5,10-methylenetetrahydrofolate reductase), MTHFD/S 
(5,10-methylenetetrahydrofolate dehydrogenase/cyclohydrolase), FTHFS 
(formyltetrahydrofolate synthetase), TS (thymidylate synthase). Reaction of 
















































































































Tetrahydrofolate (THF) is the basic folate core (Figure 1.1) that is converted to other 
folate cofactors in one-carbon metabolism.  Folates are generated to transfer methyl 
(N5-methyl-THF), methylene (N5,N10-methylene-THF) or formyl (N10-formyl-THF) 
groups. N10-formyl-THF is required for de novo purine biosynthesis (becoming carbons 
C2 and C8), pathways that are well studied [35, 36]. In protein biosynthesis, a formyl 
group derived from N10-formyl-THF and attached to a methionyl tRNA, such that 
tRNAfMet initiates translation [37-39]. While the utilization of N10-formyl-THF in purine 
metabolism and protein synthesis has been investigated in detail, recent work has 
identified N10-formyl-THF as a required cofactor in other biochemical reactions in 
pathogenic bacteria, such as siderophore biosynthesis and N-sugar formylation on the 
bacterial surface.   
 
1.2 PurH – A bifunctional AICAR transformylase/cyclohydrolase.  
PurH performs one of the last steps of purine biosynthesis and is a bifunctional enzyme 
containing aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase and 
inosine monophosphate (IMP) cyclohydrolase activities. AICAR transformylase 
catalyzes the production of formyl-AICAR (FAICAR) from AICAR (Figure 1.2, B). 
FAICAR is transferred to the second domain, IMP cyclohydrolase, to produce inosine 
monophosphate. Both in solution and in the crystal structure, PurH is a homodimer with 
the monomers heavily intertwined around each other with 5000 Å of buried surface area 
[40]. The N-terminal domain of the protein is IMP cyclohydrolase while the C-terminal 


























Figure 1.2. AICAR transformylase. (A) This bifunctional protein is a homodimer with two 
monomers intertwined around each other. The active site is located in the interface between the 
monomers. AICAR transformylase is larger of two subunits with transition state inhibitor (green) 
in the active site. (B) Reaction catalyzed by AICAR transformylase (C) AICAR (PDBID:1OZ0) 
has been crystallized in presence of transition state inhibitor with substrate and cofactor 
molecules joined together (green). Catalytic Lys267 (yellow) is hydrogen bonding distance away 
from the location of formate group on the cofactor. This residue stabilizes the transition state 
and provides the proton necessary for the formyl transfer. Other catalytic residues His268 
(yellow) and His593 (from the opposing monomer, pale yellow) are proposed to be responsible 








transformylase domain is comprised of three structural domains [41]. The first two 
domains have a very similar fold containing a five-stranded b-sheet core surrounded by 
helices. Both of these domains from each protein dimer contribute one b-sheet to make 
a 4 b-sheet bridge between IMP cyclohydrolase and AICAR transformylase. This barrier 
between the domains has been used as an argument against tunneling or movement of 
the intermediate FAICAR between the domains [40].  The third domain is represented 
as a small insertion into one of these domains with still unknown function. The active 
site of the AICAR transformylase is surface exposed and located in the dimer interface 
(Figure 1.2, A). Interestingly enough, a monomer of AICAR is not functional and the 
dimer is required for catalysis. Functional and structural studies of AICAR 
transformylase with a multi-substrate adduct inhibitor comprised of AICAR covalently 
linked to a THF analogue, were undertaken.  A holo structure with this inhibitor bound 
implicated Lys267, His268 and His593 as residues important in catalysis (Figure 1.2, C) 
[42]. The proposed mechanism suggests a catalytic triad of histidine residues are used 
as a proton shuttle from the solvent to activate the primary amine of the substrate. The 
lysine stabilizes the oxyanion hole created by the formate in the transition state, 
protonation of the lysine regenerates the catalytic triad and the protons are returned 
back to the solvent [41, 42] (Figure 1.2, C and Figure 1.5) 
 
1.3 Examples of GART enzymes. 
Glycinamide ribonucleotide transformylases (GART) catalyze the formylation of 
glycinamide ribonucleotide with N10-formyl-THF used as a formyl group donor. In purine 
biosynthesis, this enzyme is PurN and has been well studied both structurally and 
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functionally as it was considered a potential drug target. GART is composed of a 
Rossmann fold with 6-7 b-strands in the center of the molecule surrounded by a-helices 
with two subdomains. The N-terminal subdomain is responsible for binding of the THF 
cofactor and contains a folate binding loop while the C-terminal subdomain contains the 
active site loop and the catalytic His, Asn and Asp residues (Figure 1.3). The active site 
of the enzyme is surface exposed and is located at the interface of the two domains. 
The active site loop contains a conserved Asp residue as part of C-terminal domain. 
The importance of this loop has been studied in detail in human PurN where loop 
movement is directly correlated to the pH of the solution. For example at high pH (8.5) 
loop is ordered and readily binds the substrate, while at low pH this loop is disordered 
and prevents substrate binding [43]. In the Mycobacterium tuberculosis PurN, these 
studies could not be replicated, likely due to the different packing of the M. tubeclulosis 
PurN dimer (Figure 1.3) [44].  
Unlike the THF cofactor that has a distinct binding domain, the substrate is stabilized by 
folate binding loop of the C-terminal domain with the nitrogen to be modified in the 
substrate orientated toward the catalytic residues and the formate of the cofactors. 
However, substrate binding and stabilization appears to be the main difference between 
GART-like proteins in the literature. Recently, structures of three other PurN 
homologues have been solved in which the transformylase activity is merely a domain 
of a larger protein with the second domain being responsible for substrate binding. The 
homolog, methionyl tRNA transformylase (MTF)  is important in protein production and 































Figure 1.3. GAR transformylase. The enzyme is composed of 6 b-strands surrounded by 
helices. The active site is surface exposed surrounded by the active site loop (black) and the 
folate binding loop (blue). The cofactor (green) is orientated so that the formyl group and 
nitrogen of the substrate (cyan) are in binding distance of the GAR conserved catalytic triad 








transformylases are important in the LPS of Gram-negative bacteria where the growing 
sugar moiety is formylated on the S peptide in bacteria [46]. LgrA is a large 
nonribosomal peptide synthetase (NRPS) involved in gramicidin biosynthesis which 
contains a transformylation domain used as to modify the growing NRPS peptide 
(Figure 1.4) [47, 48]. Structurally, the transformylase domains in all of these enzymes 
are similar in fold to PurN (RMSD range 0.5 – 2.5 [49]) with the active site loop and 
conserved catalytic residues.  
Mechanistic and kinetic investigation of the transformylases have been done by 
Benkovic and colleagues with studies predominantly oriented toward the E. coli PurN 
enzyme. Detailed turnover kinetic experiments suggest that the transformylation occurs 
via the bi-reactant systems in which either the cofactor or the substrate can form an 
initial complex with the enzyme [50]. However, binding of the cofactor is faster and 
preferred as the initial binding step. These data provide he basis for the current 
mechanism for transformylation, which is initiated by a nucleophilic attack of the 
terminal nitrogen of the substrate on the carbonyl of the formyl group. This event leads 
to the formation of a tetrahedral intermediate and formation of the oxyanion stabilized by 
an asparagine in the active site. A proton transfer leads to the formation of the final 
product. Even though this last step is simple, it is still debated. In one of the first 
presented structures of PurN [51], the active site contained a coordinated water 
suggesting water as the means of proton movement (Figure 1.5, B). However, in other 
structures including the PurN homologues, this water molecule was absent leading to 
the hypothesis that this proton transfer has to occur by other means. In order to provide  
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Figure 1.4. Examples of GAR transformylases. Presented are three classes of GART 
transformylases. NRPS, MTF and N-sugar transformylase (WlaRD and VioF). The N-terminus 
of these proteins (red) are structurally similar (RMSD = 2.2) with a conserved catalytic triad and 
crystallized bound with the folate cofactor (green). Active site is located in same region between 
folate loop (blue) and active site loop (black). The C-terminal domain of the proteins are very 
different and corresponds to the distinct functional characteristics of each enzyme. This C-
terminal domain as well as the loop insertion in MTF (yellow) stabilize the substrate and insures 




Figure 1.5 Active site comparison between AICAR transformylase and GART enzymes. 
(A) AICAR transformylase active site. Catalytic residues (yellow) are involved in proton transfer 
between the solvent and Lys267 that is directly supplying protons to the transition state 
intermediate (green and cyan, cyan portion of the compound is the substrate and green is the 
cofactor). (B) GAR transformylase active site. Represented is the active site with substrate GAR 
(cyan), folate cofactor (green) and catalytic residues (yellow) with one of proposed reaction 
mechanism. His108 and Asn106 (not shown) stabilize oxyanion and transition state 
intermediate while Asp144 coordinates the water molecules involved in proton transfer between 










a better overview, a closer description of the other PurN homologues is presented 
below. 
1.4 Methionyl tRNAf Met formyltransferase (MTF). 
The function of methionyl tRNA (tRNAf Met) formyltransferase is of utmost importance in 
protein translation. tRNAf Met in prokaryotes is recognized as the initial amino acid of a 
growing peptide chain. The tRNAf Met allows binding with elongation factor 2 and 
elongation factor 3 to signal the 30S subunit of the ribosome to start translation. Work 
by Shmitt et al. investigated the structural and functional aspects of MTF, the enzyme 
that formylates the methionine, in E. coli [52]. The authors provided a detailed 
comparison between MTF and GART. MTF is composed of two domains, the N-terminal 
domain that closely resembles the GART enzymes and a C-terminal domain composed 
of five antiparallel b-strands surrounded by a helices on either end. The N-terminal 
domain of MTF, while very similar to the GART enzymes (RMSD 1.4 Å), has several 
important differences that appear to be of functional importance. There is a loop 
insertion between the second b-strand and the second a-helix (yellow, Figure 1.4, MTF) 
at residues 37-45 composed of basic amino acid residues. The function of this insertion 
was unknown until the co-crystal structure of MTF with tRNA Met bound, was solved. 
The basic side chains of this insertion loop are involved in the binding of the phosphate 
backbone of the tRNA arm. The formylation efficiency of the enzyme has been shown to 
decrease four times in the absence of this insertion loop. The shape of the C-terminal 
domain was previously described as an oligonucleotide binding fold. This fold conforms 
to an orientation that allows the positively charged residues on its surface to interact 
with the L-shaped phosphate backbone of the substrate. In this way, the C-terminal loop 
 14 
binds the substrate and brings it closer to the active site and provides specificity, locking 
the substrate in place for formylation by the N-terminal domain (Figure 1.4, MTF) [45, 
52]  
 
1.5 N-Sugar transformylases.  
Transformylase activity has been shown to be of importance in the pathogenicity and 
extracellular recognition in Gram-negative bacteria. Lipopolysaccharides (LPS) are 
composed of three distinct regions: lipid A, core polysaccharide, and O-linked 
polysaccharide [53]. Diversity within this polysaccharide region is exhibited by the 
activity of N-sugar transformylases. The biosynthetic pathway describing the 
modification of sugars starts with glucose 1-phospate and involves the addition of a 
nucleotide, dehydration, and amination. N-sugar transformylases catalyze the reaction 
in which the formyl group from N10-formyl-THF is transferred to the amine of the newly 
modified sugar [53].  
Holden et al. have done extensive work with N-sugar transformylases and provided a 
couple of great examples of substrate specificities in this class of enzymes. One of the 
first examined structures was that of WlaRD, an N-sugar transformylase from 
Campylobacter jejuni [54]. While the substrate for this enzyme is not known, WlaRD 
was shown to be promiscuous, turning over both dTDP-Fuc3N and dTDP-Qui3N. The 
enzyme contains an N-terminal domain that is similar to the GART enzymes with a 
conserved catalytic triad and only one amino acid substitution in the folate binding loop 
(.SALP.). The C-terminal domain is composed of 4 antiparallel b-strands. The function 
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of this domain is hypothesized to be for docking of the substrate such that Gln 223 and 
Tyr 222 are interacting with the thiamine ring of the substrate (Figure 1.4) [54].  
Other types of enzymes from this class presented by the Holden lab include the 
characterization of VioF (Providencia alcalifaciens O30) and WbtJ (Francisella 
tularensis) [46]. While in WlaRD the transformylation occurs on the C3 amine, in VioF 
and WbtJ the transformylation is on the C4 amine. The N-terminal domain of these two 
enzymes are similar to GART and demonstrate similar structural and functional 
features. However, the C-terminal domain is very different and is composed of single a-
helix and a b-hairpin. Genthe et al. described structural differences that allow for the 
differences in substrate specificity between the two types of sugar transformylase. First, 
VioF has a Trp104, residue absent in WlaRD, that prevents the same substrate 
conformation of the two enzymes. In VioF, residues Lys77 and Asp9 bind phosphoryl 
oxygen and the pyranosyl group of the substrate. In WlaRD, however, these residues 
are substituted with Asp79 and Lys9 and are unable to make these contacts [46, 54].  
The last example of N-sugar transformylases was identified as QdtF from Providencia 
alicalifaciens O40. Like WlaRD, this enzyme catalyzed formylation on the C3 carbon of 
the sugar. What makes this example unusual is that it contains an additional third 
domain characterized as an ankyrin repeat. Composed of 33 amino acid residues in a 
helix-loop-helix motif, this domain has been demonstrated to bind the dTDP-Qui3N 
substrate. Mutation of the substrate binding residues within this repeat has been shown 
to considerably decrease the activity of the enzyme. While the actual in vivo substrate of 
this enzyme is not known, the presence of this typical eukaryotic regulatory mechanism 
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in a prokaryotic protein makes QdtF an intriguing addition to transformylase class of 
proteins [53, 55].  
 
1.6 Formylating Domain in NRPS enzymes. 
Nonribosomal peptide synthetases (NRPSs) are a class of multi domain enzymes that 
generate a variety of peptide molecules of diverse biological functions. NRPS genes are 
composed of modules in which each module is responsible for the addition of a single 
amino acid into a growing peptide chain in an assembly line fashion. Each module 
contains at least three domains: adenylation (A), peptidyl carrier protein (PCP) and 
condensation (C). The adenylation domain activates the substrate amino acids by the 
addition of adenosine monophosphate (AMP), transfers the activated amino acid to a 
phosphopantethionyl tail attached to the PCP domain.  The PCP domain transfers the 
amino acid to the condensation domain for the formation of a peptide bond with the 
upstream nascent peptide. However, in some cases the modules have additional 
tailoring domains to decorate the peptide side chain allowing for the key functional 
features of the product molecules. An example of a tailoring domain is LgrA, the initial 
NRPS involved in the biosynthesis of the antibiotic gramicidin from Bacillus brevis. This 
module formylates the N-terminal nitrogen of the initial valine residue, using N10-formyl-
THF as the formyl donor. The structure of LgrA has been described in detail by Reimer 
et al. with the N-terminal domain of the protein containing a typical formyltransferase 
domain with an active site loop and catalytic triad that is required for the transfer of the 
formyl group from THF to the substrate. The C-terminal end of protein contains a 
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module for the incorporation of the initial formylated valine and the downstream glycine 
(Figure 1.4) [47, 48].  
 
1.7 PvdF from Pseudomonas aeruginosa, a new class of transformylase. 
While AICAR transformylase and GART represent the most studied examples of 
transformylases in nature, a new class of transformylases has recently been presented 
by our lab. The PvdF enzyme from pyoverdin biosynthesis in Pseudomonas aeruginosa 
catalyzes the formylation of hydroxyornithine to make N5-formyl-hydroxyornithine. 
Identification of PvdF as a novel class of transformylases lies in both structural and 
functional evidence. Structurally, PvdF is similar to PurN, a GART, with an RMSD of 2.2 
Å over 165 Ca residues. PvdF has the conserved catalytic residues of Asp, His, Asn, 
and the active site loop. The fold of PvdF is also conserved with 6 central b strands and 
a Rossman-like fold. However, PvdF is 100 amino acids longer than PurN, the GART 
from E. coli. These additional amino acids compose secondary structural elements that 
have been inserted in both the N and the C-terminal domains of the transformylase. Our 
current hypothesis suggests that these insertions are used for stabilization of both the 
N10-formyl-THF and the substrate. Functionally, the PvdF substrate is unique in 
comparison to other transformylases. GART enzymes formylate primary amines of their 
substrates, while PvdF formylates the secondary amine of its substrate. This chemical 
property makes the terminal amine of hydroxyornithine more nucleophilic and more 
labile providing more reasons for its stabilization within the active site cavity. The PvdF 
substrate is significantly smaller in comparison to the substrates of other GART 





Figure 1.6. Structure of PvdF, hydroxyornithine transformylase from Pseudomonas 
aeruginosa. Majority of structures in Figure 1.4 have transformylase as a separate domain (red, 
Figure 1.4). PvdF however, has 100 amino acid insertions throughout the protein (gray). 
Regions of the protein that are structurally similar to GART are shown in red. Active site loop 










Currently research is underway to solve the structure of PvdF with cofactor in the active 
site and to also identify the function of newly identified additional secondary structural 
elements within this structure.  
 
1.8 AICAR and GART transformylases – structural and mechanistic comparison. 
While they catalyze similar reactions, AICAR transformylase and GART are very distinct 
both structurally and functionally. The enzymes share no significant similarity in protein 
sequence or fold. A protein sequence comparison of human AICAR transformylase and 
GART enzymes in one example, has been used to hypothesize a conservation of GART 
active residues in AICAR transformylases [56]. However, mutagenesis studies indicated 
these residues are not required in AICAR transformylase activity [41]. Structurally, 
GART has a distinct Rossmann fold with the active site located between the two 
domains where one domain is responsible for cofactor binding and other for substrate 
binding and catalysis. AICAR transformylase has an alpha beta structure composed of 
three domains with an active site located in the protein dimer interface formed from 
domains 2 and 4 of opposing dimers. Functionally, AICAR transformylase is part of the 
bifunctional enzyme where the transformylase product is used by the IMP 
cyclohydrolase to make the final product. In GART, there are no examples of 
bifunctionality. Nevertheless, GART domains have been part of other transformylases 
where additional C-terminal domains were associated with substrate stabilization, or 
allosteric regulation of enzyme function (Figure 1.4). 
It is also interesting to note that in purine metabolism both GART and AICAR 
transformylase have enzyme alternatives to make their respective products. For GART 
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reaction this is PurT and for AICAR transformylase this is the PurP gene. Both PurP and 
PurT use ATP to incorporate intercellular formate instead of using formate from the 
folate cofactor. PurT and PurP belong to the enzyme superfamily known as ATP-grasp 
enzymes [57]. These enzymes have a proposed acylphosphate intermediates that allow 
the transfer of an activated carbon unit via the nucleophilic attack of the amine of the 
substrate [58].   
Mechanistic aspects of these two proteins are also different where composition of the 
substrate and the catalytic residues play key roles in formyl group transfer (Figure 1.5). 
The nucleophilicity of the formylated amines on the substrates of two proteins is 
different [42]. Positioning the formylated amine of AICAR close to the aromatic residues, 
due to resonance make this amine very unlikely to make the first nucleophilic attack to 
the formyl group of the cofactor without assistance of the residues in the active site. 
Two histidine residues, using the proton from the solvent, allow the lowering of the pKa 
of this amine [42]. In the case of GART, the initial step can proceed without direct 
involvement of active site residues. The active site residues in this transformylase seem 
to be used for stabilization of the transition state and proton transfer from the substrate 
to the cofactor.  Differences in the catalytic proton movement in the two enzymes were 
outlined in mutagenetic studies of PurN and PurH. In mutagenetic studies of PurN, the 
conclusion suggest that no one residue is absolutely necessary for the activity of this 
enzyme. Indeed, one amino acid substitution of any conserved residues decreases the 
activity, while two or more mutations abolishes the activity of the enzyme [59]. Unlike 
PurN, PurH active site mutagenesis indicated an absolute requirement of all the 
residues in catalysis. These data demonstrate not only that the PurN active site is very 
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amenable to amino acid substitution but also the utilization of solvent in catalysis of 
these two enzymes. In GART, solvent or a water molecule is used to move protons in 
the transition state while in AICAR transformylase, activation of the formylated amine of 
the substrate is through the His residues that act as a proton shuttle between the 
solvent and the active site (Figure 1.5).   
 
1.9 RibB enzyme from riboflavin biosynthesis. 
All B-group vitamins have very important metabolic functions [60]. One of these 
vitamins, B2, otherwise known as riboflavin, is a crucial precursor for the production of 
the cofactors flavin adenine dinuclotide (FAD) and flavin adenine mononucleotide 
(FMN). These compounds are essential in redox and electron transport reactions in all 
forms of life [60, 61]. Besides this, riboflavin has been associated with a multitude of 
other functions such as: folate synthesis [60], iron absorption [62], carcinogen 
associated DNA damage [63] and inflammatory and immune response [64, 65].  
Biosynthetic production of riboflavin is reserved for plants and bacteria. The gene 
cluster responsible for riboflavin synthesis in mammals is absent and riboflavin is mostly 
obtained from the diet. Due to this, research on riboflavin biosynthesis has drawn a lot 
of attention as a method for designing new antibacterial/ antimicrobial agents [66-68] 
Riboflavin is made by the rib gene cluster which is composed of five genes, ribABCDE. 
As proposed by Bacher [61, 69], riboflavin biosynthesis is divided into two branches 
(Figure 1.7). In brief, biosynthesis starts with a molecule of GTP and the enzyme RibA, 
which is responsible for the removal of carbon C8 of the GTP nucleotide as formate. 
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The RibA product is transformed by RibD, which performs deamination of the pyrimidine 
ring as well as reduction of the ribose ring. In the other branch, a molecule of ribulose 5- 
phosphate (Ru5P) is converted by RibB to 3,4 dihydroxy-2-butanone phosphate (DHBP) 
releasing carbon C4 of the substrate as formate. RibE uses the products from the two 
branches to make ribityl dimethyllumazine. In the final step RibC catalyzes an 
interesting reaction where the enzyme uses two molecules of ribityl dimethyllumazine to 
make one molecule of riboflavin and reforms the RibD product that is recycled in the 
biosynthetic pathway [70].  
RibB is a magnesium dependent enzyme. Research presented here suggests that this 
enzyme requires a single metal for catalysis. Also, I have provided evidence that 


















Figure 1.7. Biosynthetic pathway of riboflavin. Riboflavin is made from the gene cluster 
composed of five enzymes RibA-RibE. Pathway is divided into two branches. First branch starts 
with a molecule of GTP and action of RibA enzyme and second with a molecule of ribulose 5-
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PvdF, hydroxyornithine formyltransferase from Pseudomonas aeruginosa 
The work discussed in this chapter has been published in the following research 
article: 
Kenjić N. , Hoag M.R., Moraski G.C., Caperelli C.A., Moran G.R., Lamb A.L., PvdF of 
pyoverdin biosynthesis is a structurally unique N10-formyltetrahydrofolate-dependent 
formyltransferase, Arch Biochem Biophys (2019) 664: 40-501 
 
2.1 INTRODUCTION 
Pseudomonas aeruginosa is a gram-negative, opportunistic pathogen.  It causes 
nosocomial infections in  individuals with compromised immune systems (like burn 
victims and HIV patients) [1, 2] and pneumonia in individuals with cystic fibrosis [3]. 
According to the CDC, 51,000 patients are diagnosed with Pseudomonas-related 
infection per year, with 13% of these attributed to antibiotic resistant infections [4].  Due 
to an increase in antibiotic resistance of P. aeruginosa, it has been included in a group 
known as ESKAPE pathogens, group of pathogenic bacteria, both Gram-positive and 
Gram-negative, leading causes of nosocomial infections  [5-7]. Antibiotic resistance of 
P. aeruginosa can be attributed to its ability to live in a biofilm form [8] and a plethora of 
different virulence factors [1]. Virulence factors can be proteins involved in development 
of acute infections (exoenzyme S, phospholipase C, immunoglobulins G), natural 
                                               
1 Contributions of the co-authors: Kenjić - performed the kinetic analysis and solved crystal structure, 
wrote the draft of the manuscript; Hoag – performed mass spectrometry analysis and provided respective 
data; Moraski – prepared OHOrn; Caperelli – prepared fDDF and DDF; Moran – mentor of Hoag, 
provided access and training for the mass spectrometry experiment, consulted on kinetic experimental 
design and interpretation, edited manuscript; Lamb – mentor of Kenjic, provided resources and training 
for experimentation, assisted with data analysis and manuscript preparation   
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products linked to chronic infections (siderophores such as pyoverdine or pyochelin or 
quorum sensing molecules such as N-acylhomoserine lactone [9]), or transcription 
regulatory systems [10]. In order to explore new approaches to control infection by this 
pathogen, researchers have turned to studies of some of these virulence factors.  
One virulence factor of particular interest for chronic infections is involved in iron 
acquisition. Iron is critical for the function of enzymes in redox reactions, secondary 
metabolism, and DNA repair [11]. Therefore, during an infection, a pathogen needs to 
ensure a constant supply of iron to survive. For example, opportunistic pathogens such 
as Pseudomonas aeruginosa require 1µM of Fe for development. However, Fe(III) is 
insoluble and very limited in an infection environment, with concentration of about 10-
19M in human serum [12]. Iron can be acquired by bacteria through either direct or 
indirect means [13]. Pathogens can directly obtain iron from the environment (host or 
other bacteria) in the form of ferrous iron or by using iron acquisition proteins and 
cofactors such as lactoferrin [14], transferrin [15], ferritin and heme [16]. However, when 
iron in the environment is scarce, bacteria acquire iron by secretion of low-molecular 
weight, high-iron affinity molecules known as siderophores.  
To ensure appropriate chelation that is ferric iron-specific, pathogens can vary 
siderophore functional groups and size. Depending on environmental conditions such 
as pH, pathogens secrete siderophores that allow for optimum iron chelation. As such, 
siderophores can be divided into five categories by functional group: hydroxamate, 






Figure 2.1. Classes of siderophores. Siderophores can be divided into five classes depending 







P.aeruginosa  primarily makes siderophores called pyoverdin and pyochelin. Previous 
studies have shown that pyoverdin is vital in virulence as well as biofilm development 
(ref) and as a signaling molecules in quorum sensing [8]. Structurally, pyoverdins are 
composed of a chromophore, an 8-12 amino acid linker peptide and a cyclic peptide 
portion, which is assembled by nonribosomal peptide synthethase (NRPS) enzymes. 
The length and backbone composition of the linker peptide  varies between  species of 
Pseudomonas [7], which has led to the characterization of over 50 pyoverdins divided 
into 3 different types [7].  Amino acids used in pyoverdin synthesis can be either 
proteogenic or non-proteogenic in origin and can include: D-amino acids, D-
hydroxyornithine, cyclized-dN-hydroxyornithine, b-hydroxyaspartic acid, b-
hydroxyhistidine [7]. Pseudomonas aeruginosa is one of two Pseudomonas species that 
contains the genes for synthesis of N5-formyl-N5-hydroxyornithine (fOHOrn), a modified 
amino acid used as an accessory for iron chelation in all three pyoverdine groups made 
by this pathogen. N5-formyl-N5-hydroxyornithine is made by two enzymes, PvdA and 
PvdF, and subsequently incorporated into pyoverdine via NRPS enzymes PvdJ and 
PvdI (Figure 2.2) [8]. PvdA, ornithine hydroxylase, was previously structurally and 
biochemically characterized, and shown to catalyze the formation of hydroxyornithine 
from ornithine using molecular oxygen, FAD, and NADPH [17]. It was hypothesized that 
PvdF utilizes hydroxyornithine to make formyl hydroxyornithine; however, the structure 
and mechanism had not been determined before this work (Figure 2.2). Previous 
studies had shown that a deletion strain of PvdF does not produce pyoverdine and is 
avirulant [18]. Furthermore, cell extracts of the PvdF deletion strain were not able to 






Figure 2.2. Role of PvdF in pyoverdin biosynthesis. (A) PvdA and PvdF derivatize ornithine 
to generate the precursor N5-formyl-N5-hydroxyornithine (fOHOrn). This molecule is 
subsequently incorporated into pyoverdin by nonribosomal peptide synthetases PvdF catalyzes 
formyl group transfer from N10-formyltetrahydrofolate (N10-fTHF) to N5 of N5-hydroxyornithine. In 
literature two other sets of enzymes have been show to catalyze reactions identical to 
PvdA/PvdF, Rmo/Rft form rhodochelin biosynthesis and CchB/CchA from coelichelin 
biosynthesis (B) Chemical representation of N10-formyl-THF (right) and cofactor analogue fDDF 
(left).  The ring altered between the cofactor and the analogue is highlighted in blue. 
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Genes that produce proteins that are functionally similar to  PvdA and PvdF have been 
reported in clusters responsible for the synthesis of other siderophores like rhodochelin 
(Rhodococcuss jostii RHA1) [19], cholichelin (Streptomyces coelicolor) [20] and 
amychelin (Amycolatopsis sp.AA4) [21].  These siderophores are made by NPRS 
enzymes and the hydroxamate group on formyl-hydroxyornithine is used to chelate iron. 
Of these, only the rhodochelin enzymes Rmo and Rft and cholichelin enzyme CchB 
have been enzymatically characterized. While Rmo and CchB perform the same 
reaction as PvdA, Rft catalyzes the formylation reaction using N10-formyl THF as a 
substrate. While PvdF, Rft and CChA share 12.8% with PvdA, Rmo and CchB share 
35.4% sequence identity. [19] (Figure 2.2). 
Here I report the structural characterization of a hydroxyornithine transformylase, PvdF 
from Pseudomonas aeruginosa. The structure reveals a core fold common among N10-
fTHF-dependent transformylases, including the glycinamide ribonucleotide 
transformylases (GART) [22-26], the methionyl-tRNA transformylase (MTF) [27, 28], 
and N-sugar transformylases of O-antigen formation [29-33].  However, the structure 
reveals large, unique insertions that we propose are important for binding the substrate 
OHOrn, and that place PvdF as the first documented member of a new structural 
subclass.  This work includes a steady state kinetic analysis that indicates a partially 






2.2 MATERIALS AND METHODS 
 
2.2.1 Preparation of PvdF overexpression plasmid. 
The pvdF gene was cloned from Pseudomonas aeruginosa (PAO1) genomic DNA, 
using polymerase chain reaction (PCR) with Herculase polymerase (Stratagene). The 
reaction was supplemented with 8% (v/v) DMSO as per manufacturer instructions due 
to high G-C content (61%). The forward primer (5’-AAT TAT ATA CAT ATG ACG AAA 
AGG AAA CTG GCC TA -3’) contains an NdeI restriction site (underlined), and the 
reverse primer (5’-AAT ATA ATA CAG ATC TGG GAG CTT CTC GGC GAG CAG C-3’) 
contains an BglII restriction site (underlined). The amplified DNA fragment was ligated 
into the correspondingly digested pET29b vector (Novagen) with T4 DNA ligase (New 
England BioLabs). The overexpression plasmid generates the PvdF protein with a C-
terminal thrombin cleavage site followed by a histidine tag. This construct was further 
modified by site-directed mutagenesis to incorporate two stop codons at the C-terminus 
of the PvdF sequence so that the native PvdF protein, without purification tags, could be 
expressed. The Quik-Change® site-directed mutagenesis kit (Stratagene) was used with 
the forward primer (5’-CTG CTG GCC GAG AAG CTC TGA TGA CTG GGT ACC CTG 
GTG-3’) and reverse complement primer (stop codons underlined).  
 
2.2.2 Preparation of K72A,K74A-PvdF expression plasmid.  
The PvdF K72A,K74A expression plasmid was prepared by the Genscript plasmid 
preparation and mutagenesis services. The pvdF gene was cloned into the pET29b 
expression plasmid at the HindIII restriction site on the 3’ end and the NdeI restriction 
 35 
site on the 5’ end following the stop codon. The gene was synthesized such that the 
codon for K72 (AAA) was changed to encode alanine (GCA) and the codon for K74 
(AAG) to encode alanine (GCG).  
 
2.2.3 Wildtype PvdF expression and purification. 
The PvdF plasmid was transformed into BL21(DE3) E.coli (New England BioLabs) for 
expression.  Baffled flasks containing 1 L of LB Miller media containing 50 μg/ml of 
kanamycin were inoculated with 10 mL of overnight culture and grown at 37 oC in a 
shaker incubator (225rpm). When the OD600 reached 0.5, the temperature was lowered 
to 25 oC and allowed to equilibrate for 15 min. Expression was induced with isopropyl-b-
D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.2 mM with shaking 
incubation for 16 hours. The cells were harvested by centrifugation (6000 x g, 5 min, 4 
oC). The cell pellets were resuspended in 20 mL of 50 mM Tris-HCl pH 8.5 and lysed by 
three passes through a French press apparatus (35,000 psi). The lysate was 
centrifuged (12000 x g, 30 min, 4 oC) and the supernatant was injected onto a Source 
30Q affinity column (GE Healthcare) pre-equilibrated with 50 mM Tris-HCl pH 8.5. The 
protein was eluted with a linear gradient of increasing NaCl to 500 mM. Protein fractions 
containing PvdF were confirmed by 15% SDS-PAGE and pooled. The salt concentration 
was adjusted to 1 M final concentration by slow addition of solid NaCl with gentle 
mixing. The protein was injected onto a Source Phenyl Sepharose (GE Healthcare) 
column pre-equilibrated in 50 mM Tris-HCl pH 8.5, 1 M NaCl. The PvdF protein was 
eluted from the column using a gradient to a buffer with no NaCl (50 mM Tris-HCl pH 
8.5). Fractions containing PvdF were concentrated and injected onto a Superdex 200 
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gel filtration column (GE Healthcare) pre-equilibrated in 50 mM potassium phosphate 
pH 7.4. PvdF eluted at a molecular weight consistent with monomeric protein. The 
protein was concentrated with an Amicon® Ultracell® 30K centrifugal filter to 70 mg/mL 
as determined by Bradford assay, and stored at -80 oC.  The purification protocol 
yielded 148 mg per liter of culture. 
 
2.2.4 Expression and purification of K72A,K74A-PvdF. 
The K72A,K74A-PvdF expression plasmid was transformed into BL21(DE3) E.coli (New 
England BioLabs).  The variant protein was expressed and purified in a similar manner 
to wildtype PvdF, except that the phenyl sepharose column was not required to attain 
high purity.  Therefore, the protein eluted from the Source 30Q affinity column was 
directly injected onto the Superdex 75 gel filtration column.  This preparation yielded 55 
mg of protein per liter of cell culture.  
 
2.2.5 Selenomethionine substituted PvdF expression and purification.  
Se-Met PvdF was produced according to the protocol by Van Duyne et al.[34] with 
some modifications.  M9 minimal media was augmented with 2 mM MgCl2, 0.1 mM 
CaCl2, 0.4% (w/v) glucose and 50 µg/mL kanamycin.  Growth cultures (1L) were 
inoculated with 10 mL of overnight culture and incubated at 37 oC in a shaker incubator 
(225 rpm) until an OD600 of 0.5 was reached. The temperature was lowered to 25 oC 
and an amino acid mixture was added to inhibit methionine production and allow for 
selenomethionine incorporation (the amino acid mixture included: 100 mg each of 
lysine, phenylalanine, threonine; 50 mg each of isoleucine, leucine, valine; 60 mg of 
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selenomethionine, per liter of culture). When the OD600 of the culture reached 1.0, IPTG 
was added to a final concentration of 0.2 mM and the culture was incubated for a further 
16 hours with shaking. The SeMet protein purification was performed as for the native 
protein, with the exception that all buffers were supplemented with 2 mM dithiothreitol 
(DTT). The purified protein was concentrated with an Amicon® Ultracell® 30K centrifugal 
filter to 80 mg/mL as determined by Bradford assay and stored in -80 oC.  The 
purification protocol yielded 100 mg per liter of culture. 
 
2.2.6 PvdA protein expression and purification.  
The PvdA enzyme was expressed and purified as previously reported [17, 35].  
 
2.2.7 Preparation of hydroxyornithine (OHOrn).  
N5-hydroxyornithine was prepared by Garrett Moraski (Montana State University) 
according to the published protocol. [36]  
 
2.2.8 Preparation of 10-formyl-5,8 dideazafolate (fDDF) and 5,8 dideazafolate (DDF). 
Both fDDF and DDF were a generous gift from Dr. Carol Caperelli (University of 
Cincinnati). Both substrates were prepared according to the published protocols. [37]  
 
2.2.9 Steady state activity assays.  
The assay buffer contained 50 mM potassium phosphate buffer pH 7.4.  The 
deformylation of fDDF is followed by the change in extinction coefficient at 295 nm 
(Δε=18.9 mM-1cm-1)[38].  The assay was performed using a TgK scientific stopped-flow 
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instrument at 25 oC equipped with a mercury-xenon lamp. Enzyme (200 nM) with 11 
mM N5-hydroxyornithine was mixed at 1:1 ratio with varied fDDF concentration (5 μM to 
642 μM). The rate was measured for 30 sec and the rate dependence was fit to the 
Michaelis-Menten equation. When hydoxyornithine was varied, the reaction was 
performed in 96 well flat–bottom plate (Corning cat # 9107) using a Varian 50MPR 
Microplate Reader, with a total reaction mixture per well of 300 µL. Each well contained 
a final enzyme concentration of 100 nM. The hydroxyornithine concentration was varied 
from 5.8 mM to 100 mM. The reaction was initiated with addition of 150 µM fDDF; the 
highest concentration possible at the fDDF λmax, within the linear range of the 
instrument. Reaction progress was monitored at 295 nm in 1 sec cycle reads for 90 
seconds.  Data were fit to the Michaelis-Menten equation. 
 
2.2.10 Coupled steady state activity assay.  
Pseudomonas aeruginosa ornithine hydroxylase (PvdA) was used to generate the 
substrate OHOrn. The standard assay buffer contained 50 mM potassium phosphate 
buffer pH 7.4.  The reaction was performed in a 1.5 mL quartz cuvette using a Cary 50 
Bio UV-visible spectrophotometer. The initial reaction (600 μL) contained 1 μM PvdA, 
150 μM FAD, 10 mM ornithine. Varying concentrations of NADPH were added (133 μM 
to 1 mM) for PvdA to generate defined OHOrn concentrations.  The progress of the 
reaction was monitored at 300 nm as a measure of NADPH turnover.  When the change 
in absorbance at 300 nm ceased, 1 mM fDDF (final concentration) was added to the 
cuvette and the spectrometer was blanked. The transformylase reaction was initiated by 
the addition of 200 nM PvdF and monitored at 295 nm for 30 sec using a 0.5 cm 
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pathlength.  The initial rates were plotted versus [OHOrn], assuming that each NADPH 
consumed by PvdA produced one OHOrn molecule.  The plot showed a non-hyperbolic 
velocity curve, with a decreasing rate at concentrations of OHOrn above 400 μM.  
Points lower than 133 μM were not obtained due to insufficient signal-to-noise. 
 
2.2.11 Wildtype and K72A,K74A-PvdF progress curves.  
Progress curves were measured using the same buffer as the steady state assays, 
generating OHOrn with 1 μM PvdA, 150 μM FAD, 10 mM ornithine, 500 μM NADPH.  
After the reaction ceased to change at 300 nm, the PvdF reaction was initiated by the 
addition of fDDF (46-183 μM) and 200 nM PvdF. The reaction was monitored at 295 nm 
for 60 min using 0.5 cm pathlength quartz cuvette.  
 
2.2.12 Mass spectrometry.  
Samples from the PvdA-PvdF reaction were diluted 1000-fold with LC-MS grade water 
(Sigma-Aldrich), and 10 µL of each dilution was analyzed by LC-MS over 65 minutes on 
an LCMS-IT-TOF (Shimadzu Scientific Instruments) with a Shim-pack XR-ODS column. 
The mobile phase consisted of 95% of an aqueous 0.1% formic acid solution and 5% 
acetonitrile (Sigma Aldrich), with a total flow rate of 0.2 mL/min. An ESI source was 
used, and acquisition was performed in scan mode from 120-550 m/z for both positive 
and negative ion modes. A 10 msec ion accumulation time was used, and event time 
was set to 100 msec. A three stage gradient was run as follows: 5% acetonitrile for 5 
minutes, a linear gradient from 5% to 95% acetonitrile over 20 minutes, and 95% 
acetonitrile for another 20 minutes. 
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2.2.13 PvdF crystallization.  
Purified SeMet protein was exchanged into 50 mM potassium phosphate buffer pH 7.4, 
2 mM DTT and diluted to 40 mg/mL. A few flakes of powdered DDF were added to the 
protein solution, and the mixture was incubated on ice for 15 min. The protein solution 
was centrifuged (12000 x g, 30 sec, 4 oC). The protein was crystallized using the 
hanging-drop vapor diffusion method. Crystallization drops were prepared by mixing 1.5 
μL protein solution with 1.5 μL precipitant solution containing 0.55 M sodium citrate, 0.1 
M Tris-HCl pH 8.5. Rectangular-prism shaped crystals with dimensions 0.15 µm x 0.15 
µm x 0.04 µm grew within 2 weeks. For data collection, crystals were soaked in a 
cryoprotectant solution containing the precipitant solution augmented with 20% ethylene 
glycol and flash cooled in liquid nitrogen. 
 
2.2.14 Single crystal X-ray diffraction data collection and processing.  
A single wavelength anomalous dispersion (SAD) dataset was collected at the Stanford 
Synchrotron Radiation Laboratory (SSRL, Stanford, CA) beamline 12-2 using a 
wavelength of 0.9795 at 100 K. This wavelength was based on a selenium fluorescence 
scan which showed a strong signal, with an inflection point at 0.9795 Å.  The software 
package Blu-Ice [39] was used to collect 847 oscillation images (0.15 ° per image). The 
exposure time per frame was 0.2 sec with a transmission of 3%, and the crystal-to-
detector distance set at 400 mm. Diffraction data were processed using XDS[40] to 2.34 
Å with anomalous signal to 2.73 Å in the space group P21 with cell dimensions of a=128 
Å, b=92.7 Å, c=128 Å, β=90.1 °. While the crystals appeared single, the diffraction 
pattern showed twinning (overlapping lattices) making space group determination 
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problematic. Data were frequently auto-processed as P422, but had to be manually re-
processed in P21 in order to obtain the solution. Despite a strong anomalous signal, the 
SAD data did not lead to a solution using PHENIX.  Crank2 [41] in the CCP4 program 
suite[42] was used to determine the location of 24 Se atoms, providing initial phases to 
build eight monomers in the asymmetric unit. This solution had a figure of merit (FOM) 
of 0.782 and Rcomb of 0.351.  XTRIAGE[43] identified the twin fractions (-l, k, h; -h, -k, l; 
l, -k, h) with (-h, -k, l) showing the highest twin fraction of 0.49. This twin fraction was 
applied in subsequent rounds of model building and refinement using Coot [44] and 
Phenix.Refine [45]. Water molecules were added automatically and inspected manually 
using Coot. Citrate molecules, derived from the crystallization conditions, were modeled 
manually using Coot. DDF molecules were built using LigandFit [46, 47] with restraints 
generated using eLBOW [48] and REEL [49]. Statistics for data refinement and analysis 
can be found in Table 2.1. 
 
2.2.15 PvdF crystallographic model.  
The final PvdF model contains eight monomers; however, the model is discontinuous 
with several chain breaks per monomer due to disorder.  The amino acid summary can 
be found in Table 2.2.  The model contains 336 waters, seven DDF molecules and eight 
citrate molecules. The DDF molecules are located at an interface between monomers. 
Four DDF molecules are present in 100% occupancy, whereas the remaining three 
were refined to 66-73% occupancy. Final Ramachandran analysis has been calculated 



























                                               
2 Rmerge = Σh|Ih - <I>|/ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of 
all symmetry-related reflections bRcryst = Σ||Fo| - |Fc||/Σ|Fo|, Fo and Fc are observed and calculated 
structure factor amplitudes. cFive percent of the reflections were initially reserved to create an 
Rfree test set used during each subsequent round of refinement.   
  SeMet  
Data collection   
Beamline SSRL 12-2  
Wavelength (Å) 0.9795 
Space group P21 
Cell dimensions; a, b, c (Å), (o) 127.9 92.7 127.9 90 90.11 90 
Resolution (Å) 38.74 – 2.3 (2.38 – 2.3) 
Rmergea 0.089 (0.381) 
Total observations 324216 (14816) 
Total unique observations 121662 (5715) 
Mean ((I) / sd(I)) 9.2 (2.2) 
Completeness (%) 91.8 (87.4) 
CC(1/2) 0.909 (0.856) 
Redundancy 2.7 (2.6) 
Refinement   
Resolution (Å) 38.67 – 2.3 (2.38 – 2.3) 
Rcrystb 0.2270 (0.2930) 
Rfreec 0.2494 (0.3019) 
Total unique observations  121938 (12169) 
No. of non-hydrogen atoms 17617  
 Protein 16963 
 Ligand 328 
 Water 326 
rms deviation bonds (Å) 0.037 
rms deviation angles (°) 2.31 
Overall mean B-factor (Å2) 39.3 
Ramachandran plot analysise   
 Favored region 96.53 
 Allowed region 3.47 
DDF    
Chain A; occupancy, B-factor (Å2) 1.0, 30.5 
Chain B; occupancy, B-factor (Å2) none 
Chain C; occupancy, B-factor (Å2) 0.69, 25.8 
Chain D; occupancy, B-factor (Å2) 1.0, 31.5 
Chain E; occupancy, B-factor (Å2) 0.72, 25.8 
Chain F; occupancy, B-factor (Å2) 0.66, 25.3 
Chain G; occupancy, B-factor (Å2) 1.0, 21.5 
Chain H; occupancy, B-factor (Å2) 1.0, 29.6 
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                     Residues 
Monomer A 3 – 225, 231 – 274 
Monomer B 3 – 225, 231 – 274 
Monomer C 3 – 26, 30 – 80, 85 – 224, 231 - 272 
Monomer D 2 – 225, 232 – 274  
Monomer E 3 – 224, 231 – 272  
Monomer F 3 – 158, 163 – 225, 230 – 273  
Monomer G 2 – 27, 32 – 225, 229 – 275 
Monomer H 3 – 80, 84 – 225, 230 – 274  
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density. Root mean square deviation values were calculated using PDBeFold[51] and 
protein interaction interfaces were calculated using PDBePISA[52].  Structures figures 
were prepared using Pymol[53].  Atomic coordinates and structure factors for SeMet 




2.3.1 Preparation of PvdF.   
The PvdF protein was heterologously produced in E. coli and the purification was 
completed in three steps, using anion exchange, phenyl sepharose and gel filtration 
chromatography.  The 31 kDa protein eluted from the gel filtration column at a molecular 
weight consistent with monomeric protein in solution (Figure 2.3).  The SeMet protein 
was purified using a similar protocol, with the addition of a reducing agent to all buffers.  
The SeMet protein was crystallized using citrate as the precipitant, and crystals only 
formed in the presence of the product analogue 5,8-dideazafolate (DDF).  As defined in 
the Materials and Methods section, the structure determination was complicated by 
twinning.  Despite the technical difficulties, initial phase estimates for PvdF were 
determined by single wavelength anomalous dispersion phasing using the 
selenomethionine-substituted form of the protein to 2.34 Å (Table 2.1).  A 
representative electron density map of the refined structure is depicted in Figure 2.4 A, 
with example density for the DDF and a citrate molecule in Figure 2.4 B.  The 



























Figure 2.3. Size exclusion chromatography elution profile from a Superdex 200 column 
(GE Healthcare).  PvdF elutes only in the peak at 89 ml, consistent with the molecular weight of 















Figure 2.4. The asymmetric unit. (A) PvdF crystals appeared single in the drop; however, they 
showed evident twinning in the diffraction images. Refinement required implementation of the 
twin law (-h,-k,l).  Representative electron density for a 2Fo-Fc simulated annealing map 
(residues 166-174; 215-243) contoured at 1.5s is shown. (B) PvdF crystals did not form without 
the cofactor analogue DDF. Electron density at the interfaces between seven of eight 
monomers is assigned to DDF. Electron density is displayed as a 2Fo-Fc simulated annealing 
omit map contoured at 2s. (C) PvdF crystallized with eight monomers in the asymmetric unit, as 
two rings with four-fold symmetry. Each monomer is a distinct color. (D) DDF (magenta) was 
observed at an interface between PvdF monomers. PvdF monomers E,F,G,H are shown and 
the location of the active site is highlighted with two of the three residues of the catalytic triad 
shown in black (the remaining residue is part of a disordered loop). If this were a productive 
catalytic binding mode, the formate would have to travel ~22 Å.  In all other transformylases, the 


















symmetry (Figure 2.4 C). Consistent with the gel filtration data for the protein in 
solution, the average interface  
area between monomers calculated by PDBePISA[52] was 719 Å2, indicating that the 
four-fold symmetry is the result of the arrangement of the monomers in the crystal lattice 
and not indicative of an oligomeric state.  Unexpectedly contacts within this monomer-
monomer interface are mediated by the bound product analogue, 5,8 dideazafolate 
(DDF) which is not observed to bind in the putative active site, defined by the conserved 
catalytic triad (Figure 2.4 D).   
 
2.3.2 Monomer architecture.   
The core of the PvdF monomer shows the standard formyltransferase fold found in the 
N10-formyltetrahydrofolate dependent enzymes, which is Rossmann-like, with a central 
7-stranded sheet surrounded by helices and loops (Figure 2.5 A).  The fold has been 
previously divided into two subdomains: an N-terminal subdomain for binding the folate 
substrate and a C-terminal subdomain for binding the substrate to be formylated [25, 
26].   Glycinamide ribonucleotide transformylase (GART) is one of the best studied 
formyltransferases [22, 24], and E. coli GART (EcGART) will serve as a frame of 
reference for our discussion (Figure 2.5 B).  The core of PvdF and EcGART are 
structurally conserved; however, PvdF has three major structural insertions.  In the N-
terminal subdomain, EcGART has a short loop between strand 1 and helix A.  In PvdF, 
strand 1 is followed by a short helix, which is labeled helix a, and then an antiparallel β-
sheet (strands i and ii), before helix A (grey in Figure 2.5).  This is a total insertion of 23 















Figure 2.5. Walleye stereoimages showing monomer topology comparison between PvdF 
and EcGART. (A) While the formyltransferase fold and core of these proteins is similar, PvdF 
contains three major insertions sites respectively colored in gray (residues 12-34, helix a, 
strands i and ii), yellow (residues 63-102, loop and helix b) and orange (197-214, strands iii and 
iv). The N-terminal domain of PvdF (residues 1-162) in shown in magenta and the C terminal 
domain is in light pink (residues 163-275). (B) The N-terminal domain of EcGART (residues 1-
100) is shown in dark blue and the C terminal domain is in light blue (residues 101-209). 
Insertion sites are represented in same colors as in panel A. EcGART contains structural 
elements that are not seen in PvdF, helix a1 and terminal sheet b1-b2.  Helices are labeled with 
letters and sheets are indicated in numbers.  
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second β-strand and helix B is also a short loop.  Helix B is followed by another short 
loop that connects to strand 3.  PvdF has a large insertion at this connection (40 amino 
acids), beginning at residue 63.  Helix B of the Rossman fold is replaced with helix b, 
which is roughly parallel to helix a (not packed against the central sheet).  Helix b is 
followed by a long loop that does pack against the central sheet, structurally replacing 
helix B of EcGART.  PvdF does have a short turn of a helix B before it rejoins the 
standard fold at residue 102 in strand 3.  These changes are highlighted in yellow in 
Figure 2.5.  Finally, in the C-terminal subdomain, PvdF has an insertion between helix 
E and strand 6, shown in orange in Figure 2.5.  This insertion, residues 197 to 214 (18 
amino acids), forms an antiparallel β-sheet with strands labeled iii and iv.  EcGART 
continues after the F helix, with 2 additional strands forming a small sheet, structural 
elements not within the Rossmann-like fold and not found in PvdF. 
 
2.3.3 Structural homologues.   
The closest structural homologues to PvdF are the GART proteins, which are found in 
the pathway for the de novo biosynthesis of purines.  The root mean square deviation 
(rmsd) calculated for the comparison of PvdF to EcGART is 2.2 Å for 165 Cα residues 
(Figure 2.6 A and 2.6 B).  PvdF is 275 amino acids in length, whereas EcGART is 209 
amino acids.  The three insertions listed above account for most of the differences in Cα 
comparison, with other more subtle changes found within other loops.  The methionyl-
tRNA formyltransferase (MTF), which formylates the primary amine of the methionine 
attached to the initiator methionyl-tRNA, also shares a similar fold with PvdF and 






Figure 2.6. Comparison of PvdF with structural and functional homologues. (A) PvdF (B) 
GART from E.Coli (PDB:1CDE; sequence identity when compared to PvdF: 27%, calculated in 
LALIGN); (C) methionyl t-RNA transformylase from Y.pestis (PDB:3R8X; seq id: 26%); (D) VioF, 
sugar N-transformylase from P.alcalifaciens (PDB:4YFY; seq id: 28%); and (E) the NRPS 
formyltransferase domain of LgrA from B.parabrevis (PDB:5ES7; seq id: 25%).  In each case 
the darker shade is the N-terminal and lighter shade is the C-terminal domain. In the bottom row 
the transformylase is part of a large multi-functional enzyme and domains without 
transformylase activity are white. The active site loop is shown in black. Folate analogues are 
shown in yellow with respective substrates in orange. The citrate molecule from crystallization in 




compared to PvdF has an rmsd of 2.3 Å over 150 Ca residues.  The sugar N-
transformylases involved in production of modified sugars for incorporation into O-
antigens also fall into this structural and functional class.  Of these, VioF from P. 
alcalifaciens O30 showed the closest structural similarity to PvdF with an rmsd of 2.5 Å 
over 145 Ca residues (Figure 2.6 D).  Many of the sugar N-transformylases include C-
terminal domains with other catalytic activities or regulatory roles [29-33].  Recently, the 
structure of the gramicidin initiation module (LgrA) was determined, which includes a 
formyltransferase domain (Figure 2.6 E).  Interestingly, this formyltransferase domain 
has been proposed to be incorporated into the NRPS assembly line as the result of a 
gene duplication and horizontal transfer of a sugar N-transformylase [54], potentially an 
evolutionary precursor of VioF.  At the C-terminal end of the LgrA transformylase 
domain is a new structural element, a loop that includes an α-helix, that serves as a 
linker to the adenylation domain of the NRPS module [54].  Note that the secondary 
structure insertions of PvdF are unique among these enzymes (Figure 2.6), placing 
PvdF in a new structural subclass of N10-fTHF dependent transformylase enzymes. 
 
2.3.4 Folate binding pocket.   
Enzymes dependent on N10-formyltetrahydrofolate are sometimes identified by a folate 
binding motif, HxSLLPxxxG where x is any residue, in the C-terminal subdomain 
(despite the N-terminal domain being labeled the folate-binding domain) (Figure 2.7) 
[29].  The histidine in this sequence is one of three residues in the catalytic triad, 
discussed later.  This sequence starts in strand 5 and continues through the loop that 






























Figure 2.7. Walleye stereo comparison of the active sites of PvdF (A) and EcGART (B).  
EcGART contains the folate binding motif (S110-P113, light blue), that is not conserved in PvdF 
(G172-R175, light pink). The catalytic triad of Asn, His and Asp (shown in purple) is conserved 
in both PvdF and EcGART with Asp being part of the folate binding loop (shown in black). This 
loop was mobile in PvdF and not resolved. Because of unique insertions (gray and yellow, 
Panel A), PvdF contains an arginine binding pocket that contains a citrate molecule (cyan) 
derived from the crystallization mother liquor. By comparison to the binding orientation of the 
THF analogue in GART (dark green, Panel B), we propose that this arginine pocket may 






sugar transformylases and for PvdF, this sequence is not conserved.  The initial 
histidine and final glycine residues are conserved in three dimensions in PvdF.  
However, the remaining residues are not conserved, and the loop is 5 amino acids 
longer.  The resulting sequence is: 170-HxGVTRyyyyyxxxG-184, where y is any residue 
in the extended PvdF loop.  The primary contacts with the folate as determined in the 
GART and N-sugar transformylases are through hydrophobic interactions and hydrogen 
bonds between the methylpterin rings and the protein backbone found in the loop 
connecting strands 4 and 5, and in the loop connecting strands 6 and 7.  The loop 
connecting strands 4 and 5 in EcGART and most of the other transformylases includes 
a helix (labeled α1 in Figure 2.5 B).  In PvdF, this loop is similarly coiled, but does not 
make the hydrogen bonds requisite to define this as a helix.  While the residues that 
interact with the methylpterin of the folates are not conserved between the GART and 
N-sugar transformylases, the shape, hydrophobicity of the pocket, and hydrogen 
bonding interactions are.  In PvdF, the loop connecting strands 4 and 5 maintains the 
proper shape for interaction with the methylpterin rings; however, the loop connecting 
strands 6 and 7 is disordered, potentially because no folate is bound in the active site.  
This loop has been noted in other transformylases to be mobile [25, 55, 56].  We 
hypothesize that for catalysis, the folate binds in the analogous location in PvdF when 
compared to both the GART and N-sugar transformylases.  PvdF crystals would not 
grow without inclusion of a folate analogue.  However, the folates evident in the electron 
density map are found forming crystal contacts, as was described previously, rather 
than in the active site. 
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2.3.5 OHOrn binding.   
The substrates differ widely between N-transformylase groups, and include nucleotide 
precursors, sugar-nucleotides, tRNA, amino acids, and amino acids attached to a NRPS 
carrier domain through a phosphopantetheinyl linker, as documented in Figure 2.6.  It is 
not surprising that the individual substrate binding interactions are specific, with the 
ultimate goal of presenting the amine group undergoing formylation within range of the 
formyl group of the N10-formyltetrahydrofolate.  While there is no substrate bound in the 
PvdF structure, comparison to the holo-structures of transformylases previously 
determined suggests that the OHOrn substrate will bind in an analogous location 
(Figure 2.7 A).  The loop between strand 1 and helix A forms important hydrogen 
bonding and ionic interactions with the phosphates of the substrates in the GART and 
N-sugar transformylases (grey in Figure 2.7 B) [22, 25, 30, 31].  In PvdF, the loop that 
contains these amino acids is not present, and this is instead the location of the first 
major insertion.  Indeed, helix a, which is in the same three-dimensional space, has two 
sidechains, from Asn14 and Asp18, that point into the cavity and may form interactions 
with the backbone of the OHOrn substrate.  The PvdF helix a is placed more interior in 
the active site than the GART or N-sugar transformylase 1-A loop, and the Asn14 and 
Asp18 sidechains would place the substrate deeper in the active site, potentially 
accounting for the considerably shorter OHOrn substrate.   
The loop in the tRNA transformylase connecting β-strand 2 and helix B has been 
considered important for binding of the tRNA substrate [27, 28].  This loop corresponds 
with the second major insertion in PvdF; however helix b is in the comparable three 
dimensional location (yellow in Figure 2.7).  Helix b is unlikely to play a direct role in 
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hydroxyornithine binding in PvdF, being too distant from the putative substrate binding 
site.  Finally, helix F has a proline forming a kink in these homologues, not necessarily 
at the same turn in the helix, but still suitable to promote a conformation in which the N-
terminus of the helix is bent toward the substrate binding cavity.  In the GART and N-
sugar transformylases, charged and polar residues of helix F form hydrogen bonds with 
the substrates.  The analogous residue in PvdF is Arg252, which may serve a similar 
role.  In all, the location for substrate binding is likely analogous to that seen in the 
GART and sugar transformylases, but the residues that promote binding may be 
contributed at least in part by the structural features that are unique to PvdF. 
 
2.3.6 Citrate.   
The model of PvdF has a well-ordered citrate bound by three arginine residues (13, 68, 
and 111) from helix a, helix b, and helix C in every monomer (Figure 2.7 A).  The citrate 
molecule is derived from the mother liquor, which required greater than 0.5 M citrate for 
protein crystal formation.  The binding of citrate in this site is undoubtedly a 
crystallization artifact.  Nevertheless, the citrate is in close proximity of N10-fTHF binding 
site, and is bound with a free carboxylate less than 3 Å from the putative location for the 
folate glutamate tail (Figure 2.7 B).  This suggests that the citrate from the 
crystallization conditions, in large molar excess, prevented binding of folate in the active 
site.  If this is correct, Arg111 or potentially Arg115 (nearby but not bound to citrate) 
may be involved in binding the glutamate tail of N10-fTHF; however, a new crystal form 
with folate bound in the active site would be necessary to establish this.  It is important 
to note that there are no comparable binding interactions for binding the glutamate tail 
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within the previously determined N10-fTHF dependent transformylase domains: the tail is 
frequently found to be disordered or having high B-factors in structures where folate is 
bound [22, 26, 30, 31]. 
 
2.3.7 Catalytic Triad.   
The loop connecting strands 6 and 7 (black in Figure 2.6 and Figure 2.7) has been 
named both the active site loop [25] and the folate binding loop [26].  As noted before, 
this loop has been documented in other transformylases to be mobile, so it is not 
surprising that this loop is disordered in PvdF in the absence of folate.  This loop 
harbors an aspartic acid that is one of three residues in a proposed catalytic triad.  The 
other two residues, a histidine and an asparagine, are located in strand 5.  These three 
residues are conserved in PvdF: Asn168, His170, and Asp229 (purple in Figure 2.7).  
In the GART and sugar transformylases, the binding pose of the folate is such that the 
formyl group on N10-fTHF is positioned at the center of the triad [24, 29, 30].  The 
proposed mechanism for the GART enzymes, and by extension all enzymes of this 
class, suggests that the amino group of the substrate performs a nucleophilic attack on 
the carbonyl of the formyl group of N10-fTHF, generating a tetrahedral intermediate.  The 
catalytic triad residues are proposed to serve as general acid-general base residues to 
promote intermediate formation and resolution of the catalytic cycle [24, 29]. 
 
2.3.8 PvdF steady state kinetics.  
N10-fTHF dependent transformylases, such as those from purine biosynthesis, have 
been successfully assayed using the analogue 10-formyl-5,8-dideazafolate (fDDF) [38, 
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57].  When the formyl group is removed from fDDF, there is an increase in absorbance 
at 295 nm, allowing for a convenient continuous spectroscopic assay.  When OHOrn is 
held in excess, and the varied substrate is fDDF, kinetic parameters are readily 
determined: Km = 60 ± 10 µM, kcat = 1.7 ± 0.1 sec-1 (Figure 2.8, red curve).  However, 
the converse reaction, with fDDF in excess and OHOrn as the varied substrate, yielded 
a physiologically improbable Km value:  Km = 30 ± 10 mM, kcat = 1.0 ± 0.2 sec-1 (Figure 
2.9).  Furthermore, the experiment was not repeatable with each subsequent 
experiment showing an increase in Km and a decrease in kcat.  The Km effect can be 
rationalized as OHOrn is known to be unstable [58-60], and so the effective substrate 
concentration was diminishing with time.  We hypothesized that a solution to this 
problem was to have the preceding enzyme of the biosynthetic pathway, the ornithine 
hydroxylase PvdA, generate the necessary substrate in situ.  PvdA is a flavin-
dependent enzyme that must be reduced by NADH with each catalytic cycle [17, 35, 
61].  The appropriate concentration of OHOrn was produced from PvdA by varying and 
limiting the concentration of NADH.  The steady state plot produced in this manner, 
showed a non-hyperbolic velocity curve (blue in Figure 2.8).  The curve does not fit well 
to a Michealis-Menten or a substrate inhibition model.  Instead, the data suggest a 
random-sequential bireactant mechanism in which the pathway for fDDF binding first is 
preferred for product generation, a model that as has been previously described for 


























Figure 2.8.  In the presence of fDDF as the varied substrate PvdF shows typical 
Michaelis-Menten kinetics (red trace, Km = 60 ± 10 µM, kcat = 1.7 ± 0.1 sec-1). In this 
experiment, the synthesized OHOrn was used.  Higher concentrations of fDDF were not 
possible due to the highly absorbant nature of the compound exceeding the linear range of the 
spectrometer. Using hydroxyornithine as the varied substrate generated by PvdA in a coupled 
assay, PvdF initially exhibits a sigmoidal curve (blue dotted trace) until 400 uM, after which the 
rate decreases. The model that best describes this behavior is a random bireactant mechanism 




























Figure 2.9. Steady state kinetics in the presence of synthesized hydroxyornithine as a 
substrate.  The high value of KM is rationalized by the instability of the OHOrn substrate.  This 
plot was generated in triplicate using a plate reader on a single day.  The kinetic constants 
derived from the above plot are Km = 30 ± 10 mM, kcat = 1.0 ± 0.2 sec-1.  On subsequent days, 























2.3.9 Product detection.   
The absorbance assay described above indicates the loss of the formyl group from 
fDDF, but not necessarily for formation of the product fOHOrn.  To confirm fOHOrn 
production, the PvdA-PvdF reaction was analyzed by LCMS, monitoring for fOHOrn 
(m/z=177.1), fDDF (m/z=466.2) and DDF (m/z=438.1) (Figure 2.10).  fOHOrn and DDF 
were observed, and the fDDF decreased in reactions containing both enzymes and all 
necessary substrates (flavin, NADH, Orn, fDDF), whereas controls that did not contain 
one of the enzymes (PvdA or PvdF) did not show production of the fOHOrn or DDF 
products. 
 
2.3.10 The observed DDF binding mode is a crystallization artifact.   
We hypothesized that the observed binding site for DDF, outside the active site and 22 
Å distant from the catalytic triad, is a crystallization artifact (Figure 2.4 D).  As 
mentioned previously, the crystals only grew in the presence of DDF, so potentially this 
binding promoted the formation of an oligomerization interface that promoted 
crystallization.  Despite >10 years of effort, these twinned crystals were the best to date 
and the only ones that produced a refined structure.  However, we now have the benefit 
of a refined structure in which we can analyze crystallization contacts.  We generated a  
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Figure 2.10.  The formation of the product fOHOrn was monitored by LCMS (black trace, 
m/z=177.0), along with DDF (blue trace, m/z=438.1) and fDDF (red trace, m/z=466.2). Unlike in 
the control samples (lower two panels), the complete reaction (top panel) shows clear formation 

































Figure 2.11. Progress curve comparison between the wild type (shade of grey) and K72A, 
K74A-PvdF variant (shades of purple/pink).  The curves represent four concentrations of 
fDDF (from light to dark shades).  The K72A,K74A-PvdF does not crystallize, suggesting that 
the crystallographic binding site for DDF is disrupted.  The variant is more active than the 











variant, K72A,K74A-PvdF.  These two lysine residues flank the DDF binding site.  In 
monomers C and D, K72 directly hydrogen bond with the glutamate tail of DDF.  K74 of 
one monomer is proximity of E65 of the next monomer in the ring, and in two of the 
eight cases, these residues form a hydrogen bond.  The double K→A variant did not 
crystallize, but the protein was active as shown in full progress curves (Figure 2. 11).   
 
Indeed, the slope of the curves for the K72A,K74A-PvdF is slightly steeper than those of 
the WT proteins, indicating that the protein is marginally more active with this variant.  
Taken together, we suggest that the K72A,K74A-PvdF variant no longer has the 
crystallographic DDF binding site, and yet is catalytically active.  Therefore, the 
catalytically relevant binding of the folate is not seen in this PvdF structure.  Instead, we 
hypothesize that in the catalytic complex, the folate will bind such that the formate to be 
transferred (attached to N10) will be adjacent to the catalytic triad, as seen in all other 




 PvdF is the formyltransferase that converts N5-hydroxyornithine (OHOrn) to N5-
formyl-N5-hydroxyornithine (fOHOrn) so that fOHOrn can be incorporated into the 
siderophore pyoverdin by a nonribosomal peptide synthetase assembly line (Figure 
2.2).   An N10-fTHF-dependent hydroxyornithine transformylase involved in siderophore 
biosynthesis has been functionally characterized previously [19].  The enzyme, 
rhodochelin formyltransferase, or Rft, is involved in the biosynthesis of the mixed 
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catecholate-hydroxamate siderophore rhodochelin by Rhodococcus jostii RHA1, a gram 
positive soil bacteria.  Like pyoverdin, this siderophore includes two 
formylhydroxyornithine residues for iron chelation, and is assembled by a nonribosomal 
peptide synthetase.  Using an HPLC-MS assay, the authors showed conversion of 
OHOrn to fOHOrn, but there are no structural data for Rft.  Sequence comparisons 
indicate that Rft is not a close structural homologue of PvdF.  Instead, Rft is likely to be 
structurally similar to either the tRNA transformylase (FMT) or the N-sugar 
transformylase ArnA, an E. coli enzyme involved in lipid A modification that 
transformylates UDP-4-amino-4-deoxy-L-arabinose [19].  Rft, FMT, and ArnA all have 
the conserved HxSLLPxxxG motif for binding the folate co-substrate that PvdF lacks, 
and they all lack the major insertions highlighted in Figure 2.5 that are specific to PvdF.  
Also unlike PvdF, they all have a C-terminal domain that provides additional 
functionality (to enhance substrate binding or to provide an additional catalytic activity).  
Finally, Rft is an allosteric enzyme showing positive cooperativity, and is proposed to be 
a tetramer in solution [19].  PvdF is a monomer in solution and in the crystals.  The 4-
fold ring structure seen in Figure 2.4 B is the result of crystal packing.  Therefore, Rft is 
more functionally and likely structurally similar to the N-sugar transformylases and the 
tRNA transformylases than to PvdF. 
 The initiation module of the NRPS for the biosynthesis of the antibiotic gramicidin 
(LgrA) includes a formyltransferase that has been structurally characterized.  The LgrA 
N10-fTHF-dependent formyltransferase domain transfers a formate to the backbone 
amine of a valine while the amino acid is covalently attached to the peptidyl carrier 
domain by a phosphopantethienyl tether [54].  This is in contrast to PvdF, which is a 
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stand-alone accessory enzyme that formylates the sidechain amine of the free OHOrn 
substrate before the product fOHOrn is activated by an NRPS adenylation domain and 
attached to the carrier domain of the PvdI or PvdJ proteins [8].  LgrA has been 
hypothesized to be an evolutionary descendent of an N-sugar transformylase [54].  Both 
LgrA and N-sugar transformylases are considerably shorter in length, and lack the 
secondary structure insertions of PvdF, again suggesting that PvdF belongs to a distinct 
structural class of N10-fTHF dependent formyltransferase. 
 PvdF maintains the 7-stranded β-sheet core in a Rossmann-like fold common to 
the N10-fTHF dependent transformylases, and the catalytic triad characteristic for this 
class of enzymes is conserved.  The structurally unique features of PvdF are likely 
responsible for interaction with the smaller amino acid substrate.  The mechanism 
previously defined for the GART enzymes and hypothesized to be conserved in the 
class likely holds for PvdF.  A detailed steady state kinetic analysis of human GART 
demonstrated an ordered-sequential kinetic mechanism in which the folate binds first 
[64].  Subsequent, pre-steady state kinetic experiments for the E. coli GART defined a 
random sequential kinetic mechanism in which folate and GAR bind in no obligatory 
order, but for which the apoenzyme has higher affinity for fDDF than GAR [57].  For 
PvdF, varying the concentration of the substrate analogue fDDF (OHOrn in excess) 
generated Michaelis-Menten kinetics with kcat and Km values in keeping with an enzyme 
from secondary metabolism.  N5-hydroxyornithine was a difficult substrate with which to 
work, and when used as the varied substrate, the data were not reproducible and 
provided kinetic values that were not physiologically relevant.  However, when the 
ornithine hydroxylase (PvdA) of the same biosynthetic pathway was used to generate 
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the OHOrn in situ, reproducible data could be generated.  Interestingly, the curve was 
nonhyperbolic and not well fit by Michealis-Menten nor a substrate inhibition model 
(Figure 2.8).  Instead, these data represent a model defined by Ferdinand [62] and later 
echoed by Segel [63] in which the bireactant system shows random binding of the two 
substrates, but favors binding of the folate over the OHOrn, very similar to the kinetic 
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3,4-dihydroxy-2-butanone 4-phosphate synthase (RibB) of riboflavin biosynthesis 




The RibB enzyme is functionally and structurally unique. Functionally, RibB is a 
magnesium-dependent enzyme that removes carbon C4 of Ru5P, a five-carbon sugar, 
to make the product DHBP, a four-carbon compound (Figure 3.1). Current evidence for 
this is mainly based on 13C feeding studies as well as 13C NMR endpoint experiments 
[1-4]. Due to the complexity of the reaction it is not surprising that the RibB reaction is 
considered to be one of the rate-limiting steps in riboflavin biosynthesis [5]. RibB 
enzymes have turnover numbers reported to be within a couple of turnovers per minute 
[6].  Structural examination of RibB testifies to its unique nature as well. At first glance, 
RibB enzymes have a+b fold (Figure 3.2). However, comparison of RibB to proteins 
deposited in the Protein Data Bank (PDB) results only in other RibB proteins. In an 
analysis using PDBeFold [7], the results yield 47 RibB proteins with best match 
corresponding to RibB from Salmonella enterica (RMSD of 0.54 Å over 203 Ca of 203 
residues) and lowest matched RibB protein from Methanocaldococcus jannaschii 
(RMSD of 1.59 Å over 191 Ca residues of 219. While the RibB fold has an a+b 






Figure 3.1. Reaction catalyzed by RibB from riboflavin biosynthesis. (A) RibB removes 
carbon C4 of ribulose 5-phosphate (Ru5P) as formate (orange), generating one molecule of 3,4-
dihydroxy-2-butanone phosphate (DHBP) (blue). (B) Isomers used in this study. Ribose 5-
phosphate (R5P) is an aldose sugar equivalent to Ru5P. Xylulose 5-phosphate is an epimer at 































































surrounded by helices) the connectivity of the secondary structural elements and protein 
topology are unique. In Gram-negative bacteria RibB enzymes have been reported to 
be dimeric in solution and in crystal structures. In Gram-positive bacteria, however, the 
RibB enzyme is found in complex with RibA. Isolation of only the RibB domain leads to 
formation of a dimer as in the Gram-negative homologues [8, 9]. The active site of the 
enzyme is surface exposed and in proximity to the dimer interface (Figure 3.2). This 
site is also surrounded with two mobile loops.  The shorter loop, loop 1, is composed of 
acidic residues and is important for binding of the substrate and metal. The longer loop, 
loop 2, has not been functionally characterized. However, major conformational 
changes are observed in this loop upon substrate and metal binding [10-12]. 
A multitude of RibB structures have been reported. The majority of these structures are 
apo structures, structures with Mn2+, Zn2+ and Ca2+, structures with sulfate or phosphate 
in the active site, and few are holo-structures with metal and substrate bound [9-17]. 
From this structural evidence it was concluded that the enzyme requires two metal ions 
for catalysis. Here we report intrinsic tyrosine fluorescence and activity assay profiles 
that show RibB binds and requires a single metal ion for full activity. We also report 
high-resolution structures of RibB with an inactive substrate analogue ribose 5-
phosphate (R5P), stereoisomers D and L-xylulose 5-phoshate (DXy5P and LXy5P) and 
1.08 Å apo-RibB structure with loop 1 in an open conformation. The structures reveal 
the location of a single metal binding site that is highly coordinated by both substrate 




Figure 3.2. RibB dimer and dimer interface. RibB is a homodimer composed of two identical 
monomers. Each monomer is represented with light and darker shade of same color (light blue 
and dark blue). Interface is composed of 10 hydrogen bonding interaction, 150 non-bonding 
interaction and one salt-bridge over 48 amino acid residues. Hydrogen bonds come 
predominantly from helix 5 (black,gray) and helix 3 (orange, light orange) interaction with 
residues 175 -185 (purple,violet). Nonbonding interactions come from polypeptide chain 
originating on either end on helix 5. Chain 1 (red, light red) start on the N-terminal end of helix 5 
and passes the interface to surround the enzyme active site of the same monomer. Location of 
the active site is represented by molecule of R5P (blue sticks). End of the chain that covers the 
active site (residues 87-96) has been represented as catalytically important loop 2. Chain 2 
(yellow, light yellow) starts on the C-terminal end of helix 5 in opposing monomer. Besides non-
bonding interaction with chain 1, it is partially buried in active site of opposing monomer where 
His137 is making a salt bridge with Glu175 and hydrogen bonding distance away from terminal 
hydroxyls of the substrate. Active site is surface exposed and covered with loop 2 on one side 








3.2 MATERIALS AND METHODS 
 
3.2.1 VcRibB cloning.  
An overexpression construct for the Vibrio cholerae RibB gene was prepared by 
Genscript plasmid preparation and subcloning services. The ribB gene from Vibrio 
cholerae (sequence ID: AE003853.1, strain: N16961, taxid: 243277) was initially 
synthesized in the pUC15 vector. The final construct was obtained by sub cloning this 
gene into pET28a+ (restriction sites: NdeI/XhoI), to yield the protein with an N-terminal 6 
His tag.  
 
3.2.2 VcRibB purification.  
Purification of 3,4-dihydroxy-2-butanone 4-phosphate synthase, RibB from Vibrio 
cholerae was done as described previously [12] with a few changes. The RibB construct 
was transformed into BL21(DE3) E.Coli (New England Biolabs) and grown overnight at 
37 oC in 50 ml of LB Miller media (150 ml conical flask) in a shaker incubator (250 rpm) 
(containing 50 μl of 50 mg/ml of kanamycin). 1L of LB Miller broth in a baffled flask 
containing 1 ml of 50 mg/ml kanamycin was inoculated with 10 ml of the overnight 
culture and grown at 37 oC in a shaker incubator (250 rpm). Protein expression was 
induced when the OD600nm reached 0.8 with a final concentration of 0.5 mM IPTG 
(isopropyl β-D-1-thiogalactopyranoside) and further incubated at 37 oC for 4 hours. Cells 
were harvested by centrifugation (6000 x g,10min, 4 oC). The cell pellet was 
resuspended in 10 ml of 50 mM Tris-HCl pH 8.0, 50 mM imidazole and 500 mM NaCl 
per liter of culture broth. Resuspended cells were lysed by passing them through French 
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press (35000 psi) three times, on ice. The cell lysate was centrifuged at 12000 x g for 
40 min at 4 oC. The supernatant was injected onto a 25 ml Nickel Superdex fast flow 
(GE Healthcare) column pre-equilibrated with 50 mM Tris:HCl, 50 mM imidazole and 
500 mM NaCl pH 8.0. The protein was eluted with a 10 column volume linear gradient 
of 50 mM Tris-HCl, 500 mM imidazole, 500 mM NaCl pH 8.0. RibB eluted at 200 mM 
imidazole. The protein (100 ml) was concentrated to 30 ml using an Amicon® nitrogen 
concentrator with a 10kDa cutoff filter and injected onto a Superdex 200 gel-filtration 
column (GE Healthcare), pre-equilibrated with 25 mM Tris-HCl pH 8.0. RibB eluted as a 
dimer and was isolated and concentrated using an Amicon® Ultracell® 30K centrifugal 
concentrators to 40 mg/ml by Bradford and stored at -80 oC for later use. The 
purification yield was 40 mg of protein per liter of culture.  
 
3.3.3 VcRibB purification in presence of EDTA.  
In order to remove as much of residual divalent ions, prior to size exclusion step, the 
protein has been incubated with final concentration of 2 mM EDTA and left on ice for 10 
min. The buffer for the size exclusion column contained 100 μM EDTA. Before start of 
the experiment, the protein was exchanged again into freshly made 25 mM Tris-HCl pH 
8.0, 100 μM EDTA prior to use in metal binding and activity studies (section 3.3.7 and 
3.3.8). 
 
3.3.4 Steady state kinetics of RibB with varied substrate, ribulose 5-phosphate (Ru5P).                                                                                                                             
Ru5P (Sigma Aldrich) was dissolved in 50 mM Tris-HCl pH 7.5 to a stock concentration 
of 90 mM. Serial dilutions of substrate, by factor of a half, were prepared with a final 
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concentration range from 4 mM to 0.5 μM. In a reaction vial of 200 μl, diluted Ru5P, 10 
μM enzyme, and 10 mM MgCl2 were mixed and incubated for 30 min at room 
temperature. After 30 min, the reaction was quenched and the color developed by 
addition of freshly made 175 μL of saturated naphthol (dissolved in 1N NaOH to 30 
mg/ml) and 250 μL of saturated creatine (dissolved in water, 35mg/ml) [6]. The color 
was left to develop for 30 min after which it was scanned between 450 nm and 650 nm 
using Cary 50 Bio UV-visible spectrophotometer. The absorbance at λmax 525 nm was 
corrected by subtracting with the absorbance at 650nm and then converted to the 
amount of 3,4-dihydroxy-2-butanone phosphate (DHBP) (in nmol) using a 3,4-butadione 
standard curve. As the concentration of the substrate was not saturating in this assay, 
steady state parameters were obtained by using the equation:  
 
𝑣 = 𝑉$%&




Values for Vmax and KM are averages of three trials and errors are reported as standard 
deviation between values. Error propagation was used in the determination of error 
values for kcat and kcat/KM.  
 
3.3.5 Steady state kinetics with varied Mg2+.  
The steady state kinetics of RibB with varied Mg2+ were determined as with Ru5P with 
one change. The standard reaction mixture (200 μL) contained diluted MgCl2 (99.9% 
pure, Fisher, 1.6 mM to 12.2 μM), 1.8 mM Ru5P and 10 μM enzyme. 
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3.3.6 Steady state kinetics with varied Mn2+.                                                                   
Steady state parameters were obtained in the same manner as with Mg2+ except 1 μM 
enzyme and pure MnCl2 (250 μM to 1.9 μM, 99% pure, Fisher) was used. 
 
3.3.7 Determination of number of metals required for activity.                                             
RibB protein purified in the presence of EDTA was exchanged into 25 mM Tris-HCl, 100 
μM EDTA pH 8.0 and concentrated to 37.7 mg/ml using an Amicon® Ultracell® 30K 
centrifugal concentrator. In each reaction of 200 μL, the final concentration of 50 mM 
Tris-HCl pH 7.5, 100 μM EDTA, 1.8 mM Ru5P and 0 to 220 μM of MgCl2 in increments 
of 20 μM were combined. The reaction was initiated by addition of 60 μM enzyme and 
incubated for 1 hour at room temperature. Steady state data were calculated using the 
above procedure. The experiment was repeated three times, and values reported are 
the averages of three trials with errors reported as standard deviations. 
 
3.3.8 Determination of number of metals required for binding.                                                      
Intrinsic tyrosine fluorescence was measured using a Cary 50 Eclipse fluorometer with 
an excitation wavelength of 280 nm and emission recorded from 290 nm to 400 nm 
(excitation slit set to 10 nm and emission slit set to 5 nm). The reaction mix, 200 μL, 
contained 50 mM Tris-HCl pH 7.5, 100 μM EDTA, 1.8mM Ru5P and 60 μM RibB (50mM 
Tris:HCl, 100 μM EDTA pH 8), was titrated in 1 μL increments of 2 mM MgCl2, 100 μM 
EDTA solution. The reported Mg2+ concentration account for the dilution. Tyrosine 
fluorescence at 302 nm was corrected with the florescence at 302 nm for the control 
sample (titration with 100 μM EDTA). Experiments were repeated three times and data 
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points reported are averages of three trials with error reported as the standard deviation 
of the respective trials.  
 
3.3.9 EPR studies of VcRibB metal binding                                                              
Depending on the sample, EPR samples were prepared by mixing millimolar ratio of 
VcRibB, MnCl2 and Ru5P (LXy5P) in 50 mM Tris-HCl pH 7.5 and 10% glycerol. In 300 
μL final volume the reaction was performed at 4 oC and initiated by direct addition of 
enzyme into the reaction mixture placed in a 4 mm quartz EPR tube. After an allotted 
time period the reaction was quenched by submerging the EPR tube in liquid nitrogen. 
X-band EPR data were collected on a 9 GHz Bruker EMXPlus spectrometer. 
Experiments were run at 10 K with the use of an Oxford ESR900 continuous-flow liquid 
helium cryostat equipped with an Oxford ITC503 temperature system. Perpendicular-
mode data were collected in a dual-mode Bruker ER4116DM cavity. Spectra were 
recorded using the following non-saturating conditions: 9.64 GHz microwave frequency, 
2.0 mW microwave power, 4 G modulation amplitude, 100 kHz modulation frequency, 
and 40.96 ms time constant.  
 
3.3.10 VcRibB crystallization                                                                                                 
All crystals were grown using the hanging-drop vapor diffusion method. Each drop (3 μl) 





3.3.11 VcRibB apo crystallization 
Protein was crystallized at 40 mg/ml. The precipitant solution contained final 
concentration of 0.1 M Na2HPO4/NaH2PO4 pH9.3, 16% PEG 3350, 0.3M glycine. Cube 
shaped crystal grew to their full size in three weeks. For data collection crystal was 
soaked in precipitant solution supplemented with 20% PEG3350, 5.2mM Ru5P and 
0.2mM MgCl2.  
 
3.3.12 VcRibB crystallization with D-ribulose 5-phosphate (D-Ru5P).                           
Purified protein at 32.9 mg/ml has been mixed with 15 times molar excess of D-ribulose 
5-phosphate in 50 mM Tris-HCl pH 7.5 (Sigma Aldrich) and incubated on ice for 15 min. 
The precipitant protein solution was 0.1 M Lithium Acetate and 18% PEG 3350. In 
preparation for data collection rod shaped crystals were first soaked in precipitant 
solution mixed with a final concentration of 40 mM D-ribulose 5-phosphate overnight, 
then soaked in cryoprotect containing precipitant supplemented with 30% ethylene 
glycol. 
 
3.3.13 VcRibB crystallization with D-ribose 5-phosphate (D-R5P) and Mn2+.             
Purified protein at 32.9 mg/ml was mixed with a few flakes of D-ribose 5-phosphate 
(Sigma Aldrich) and incubated on ice for 15 min. The precipitant solution contained a 
final concentration of 0.1 M Lithium acetate and 16% PEG 3350. Rod shaped crystals 
grew to their full size in 48 hours. For data collection, crystals were soaked in precipitant 
solution supplemented with 30% ethylene glycol and 4 mM MnCl2 (99% pure, Fisher). 
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3.3.14 VcRibB crystallization with D-xylulose 5-phosphate (D-Xy5P) with Mn2+.   
Purified protein at 32.9 mg/ml has been mixed with 15 times molar excess of D-xylulose 
5-phosphate in 50 mM Tris-HCl pH 7.5 (Sigma Aldrich) and incubated on ice for 15 min. 
The precipitant protein solution was 0.1 M Lithium Acetate and 12% PEG 3350. In 
preparation for data collection rod shaped crystals were first soaked in precipitant 
solution mixed with a final concentration of 40 mM D-xylulose 5-phosphate overnight, 
then soaked in cryoprotect containing precipitant supplemented with 4mM MnCl2 and 
30% ethylene glycol. 
 
3.3.15 VcRibB crystallization, L-xylulose 5-phosphate (L-Xy5P) with Mn2+.   
Purified protein at 32.9 mg/ml has been mixed with 15 times molar excess of L-xylulose 
5-phosphate in 50 mM Tris-HCl pH 7.5 (Sigma Aldrich) and incubated on ice for 15 min. 
Protein was crystallized using the hanging-drop vapor diffusion method. Precipitant 
protein solution was 0.1 M Lithium Acetate and 14% PEG 3350. In preparation for data 
collection rod shaped crystals were first soaked in precipitant solution augmented with a 
final concentration of 40 mM L-xylulose 5-phosphate then soaked in cryoprotect 
containing precipitant supplemented with 4mM MnCl2 and 30% ethylene glycol. 
 
3.3.16 X-ray diffraction data collection.  
Data for all RibB crystal variants were collected at the Stanford Synchrotron Radiation 
Laboratory (SSRL, Stanford, CA) beamline 12-2 using a wavelength of 0.9795 Å at 100 
K (except for apo-RibB). The software package Blu-Ice [18, 19] was used to collect 
1200 oscillation images (0.15 ° per image) with an exposure time of 0.2 sec.  
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3.3.17 X-ray diffraction data collection and processing of apo-RibB                                   
Data were collected at the wavelength of 0.8526 Å at 100K. Diffraction data were 
collected using a beam size of 50 μm x15 μm with transmission set to 1.5 % and a 
detector distance of 188.1 mm. Diffraction data were processed using XDS [20] to 1.08 
Å in the space group P 212121 with cell dimensions of a=56.84 Å, b=73.90 Å, c=95.82 Å, 
a = β = g =90.0 °. A phasing solution was obtained by molecular replacement using 
PHENIX, Phaser-MR [21] with the 4P8J as a model [12]. One molecular replacement 
solution was identified with an LLG of 28265 and a TFZ of 156. The solution was 
subjected to alternating cycles of model building and refinement using Coot [22] and 
Phenix.Refine [23, 24]. Water molecules were added automatically and inspected 
manually using Coot. Due to the high resolution, all atoms were refined with anisotropic 
factors. Statistics for data refinement and analysis can be found in Table 3.1. 
The final model has two monomers in the asymmetric unit with residues 7 to 83 and 97 
to 216 fully resolved in one monomer and residues 5 to 83 and 97 to 216 fully resolved 
in the other. The final model contained 490 water molecules. Ramachandran analysis 
was calculated with MolProbity [25] showing 97.94% in the favored regions and no 
outliers. 
 
3.3.18 X-ray diffraction data collection and processing of RibB with D-ribulose 5-
phosphate.                                                                                                               
Diffraction data were collected using a beam size of 100 μm x 60 μm with transmission 
set to 5.0 % and a detector distance of 300.4 mm. Diffraction data were processed 
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using XDS [20] to 1.80 Å in the space group C 2 2 21 with cell dimensions of a=60.67 Å, 
b=78.63 Å, c=90.32 Å, a = β = g =90.0 °. A phasing solution was obtained via molecular 
replacement using PHENIX, Phaser-MR [21] with the 4P8E as a model [12]. One 
molecular replacement solution was identified with an LLG of 5323 and a TFZ of 51. 
The solution was subjected to alternating cycles of model building and refinement using 
Coot [22] and Phenix.Refine [23, 24]. Water molecules were added automatically and 
inspected manually using Coot. The ribulose 5-phosphate molecule was added 
manually. Restraints for ribulose 5-phosphate was generated using eLBOW [26] and 
REEL [27]. Statistics for data refinement and analysis can be found in Table 3.1. 
The final model has one monomer with residues 2 to 217 fully resolved. The final model 
contained 148 water molecules and molecule of ribulose 5-phosphate in the active site. 
Ramachandran analysis has been calculated with MolProbity [25] with 97.2% in the 
favored regions and no outliers. Structures figures were prepared using Pymol [28]. 
 
3.3.19 X-ray diffraction data collection and processing of RibB with D-ribose 5-
phosphate and Mn2+.                                                                                                
Diffraction data were collected using a beam size of 100 μm x 60 μm with transmission 
set to 17.5 % and a detector distance of 351.6 mm. Diffraction data were processed 
using XDS [20] to 2.0 Å in the space group C 2 2 21 with cell dimensions of a=60.25 Å, 
b=78.58 Å, c=89.93 Å, a = β = g =90.0 °. A phasing solution was obtained by molecular 
replacement using PHENIX, Phaser-MR [21] with 4P8E as a model [12]. One molecular 
replacement solution was identified with an LLG of 3913 and a TFZ of 43. The solution 
was subjected to alternating cycles of model building and refinement using Coot [22] 
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and Phenix.Refine [23, 24]. Water molecules were added automatically and inspected 
manually using Coot. The ribose 5-phosphate molecule and the manganese were 
added manually. Restraints for ribose 5-phosphate were generated using eLBOW [26] 
and REEL [27]. Statistics for data refinement and analysis can be found in Table 3.1. 
The final model has one monomer in the asymmetric unit with residues 3 to 217 fully 
resolved. The final model contained 68 water molecules, one molecule of ribose 5-
phosphate and one Mn2+ ion in the active site. Ramachandran analysis was calculated 
with MolProbity [25] showing 95.8% in the favored regions and 0.94% of outliers. 
Outliers belong to residues Ser 5 and Asp 214 that are in areas of poor electron density. 
 
3.3.20 X-ray diffraction data collection and processing of RibB with D-xylulose 5-
phosphate and Mn2+.                                                                                                    
Diffraction data were collected using a beam size of 150 μm x 80 μm with transmission 
set to 35.0 % and a detector distance of 390.0 mm. Diffraction data were processed 
using XDS [20] to 2.0 Å in the space group C 2 2 21 with cell dimensions of a=61.03 Å, 
b=79.11 Å, c=91.34 Å, a = β = g =90.0 °. A phasing solution was obtained by molecular 
replacement using PHENIX, Phaser-MR [21] with 4P8E as a model [12]. One molecular 
replacement solution was identified with an LLG of 4225 and a TFZ of 48.3. The 
solution was subjected to alternating cycles of model building and refinement using 
Coot [22] and Phenix.Refine [23, 24]. Water molecules were added automatically and 
inspected manually using Coot. D-xylulose 5-phosphate molecule and the manganese 
were added manually. Restraints for D-xylulose 5-phosphate were generated using 
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eLBOW [26] and REEL [27]. Statistics for data refinement and analysis can be found in 
Table 3.1. 
The final model has one monomer in the asymmetric unit with residues 3 to 86 and 94 
to 217 fully resolved. The final model contained 106 water molecules one molecule of 
D-xylulose 5-phospahte one Mn2+ ion in the active site and two ethylene glycol 
molecules. Ramachandran analysis was calculated with MolProbity [25] showing 
98.54% in the favored regions and no outliers.  
 
3.3.21 X-ray diffraction data collection and processing of RibB with L-xylulose 5-
phosphate and two Mn2+metal ions.                                                                         
Diffraction data were collected using a beam size of 100 μm x 60 μm with transmission 
set to 59.0 % and a detector distance of 347.1 mm. Diffraction data were processed 
using XDS [20] to 2.0 Å in the space group C 2 2 21 with cell dimensions of a=60.37 Å, 
b=79.02 Å, c=91.35 Å, a = β = g =90.0 °. A phasing solution was obtained via molecular 
replacement using PHENIX, Phaser-MR [21] with 4P8E as a model [12]. One molecular 
replacement solution was identified with an LLG of 3586 and a TFZ of 45. The solution 
was subjected to alternating cycles of model building and refinement using Coot [22] 
and Phenix.Refine [23, 24]. Water molecules were added automatically and inspected 
manually using Coot. L-xylulose 5-phosphate molecule and two manganese ions were 
added manually. Restraints for L-xylulose 5-phosphate were generated using eLBOW 
[26] and REEL [27]. Statistics for data refinement and analysis can be found in Table 
3.1. 
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The final model has one monomer with residues 2 to 217 fully resolved. The final model 
contained 120 water molecules, a molecule of L-xylulose 5-phospahte and two Mn2+ 
ions in the active site. Ramachandran analysis has been calculated with MolProbity [25] 
with 97.66% in the favored regions and no outliers. Structures figures were prepared 































                                               
3 Rmerge = Σh|Ih - <I>|/ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of 
all symmetry-related reflections bRcryst = Σ||Fo| - |Fc||/Σ|Fo|, Fo and Fc are observed and calculated 
structure factor amplitudes. cFive percent of the reflections were initially reserved to create an 




  RibB-apo RibB-Ru5P RibB-R5P  RibB-DXy5P RibB-LXy5P 
Data collection       
Beamline SSRL 12-2 SSRL 12-2 SSRL 12-2 SSRL 12-2 SSRL 12-2 
Wavelength (Å) 0.9795 0.9795 0.9795 0.9795 0.9795 
Space group P212121 C2221 C2221 C2221 C2221 
Cell a, b, c (Å) 56.84 73.90 95.82 60.67 78.63 90.32 60.25 78.58 89.93 61.03 79.11 91.34 60.37 79.02 91.35 
Resolution (Å) 36.95 - 1.08 (1.10 - 1.08) 39.31 - 1.80 (1.84 -1.80) 39.29 - 1.95 (2.0 - 1.95) 39.55 – 2.0 (2.05 – 2.0) 39.51 - 2.0 (2.05 - 2.0) 
Rmergea 0.066 (0.865) 0.084 (0.600) 0.085 (0.868) 0.069 (0.418) 0.075 (0.418) 
Total observations 1128679 (48565) 135338 (6988) 104193 (6753) 99522 (7084) 99288 (6060) 
Total unique observations 172713 (8395) 20407 (1209) 15760 (1092) 15176 (1092) 15092 (1060) 
Mean ((I) / sd(I)) 13.0 (2.3) 13.0 (2.3) 12.4 (2.0) 16.7 (4.2) 16.9 (3.8) 
Completeness (%) 99.8 (98.7) 99.9 (99.6) 98.8 (97.0) 99.3 (99.3) 99.6 (97.0) 
Redundancy 6.5 (5.8) 6.6 (5.8) 6.6 (6.2) 6.6 (6.5) 6.6 (5.7) 
CC(1/2) 0.945 (0.028) 0.998 (0.869) 0.999 (0.778) 0.998 (0.904) 0.999 (0.903) 
Refinement      
Resolution (Å) 36.95 - 1.08 (1.12 - 1.08) 39.31 -1.8 (1.9 – 1.8) 36.01 – 1.95 (2.0 – 1.95) 36.3 -2.0 (2.1 - 2.0) 36.26 - 2.0 (2.1 - 2.0) 
Rcrystb 0.1306 (0.1875) 0.1633 (0.2081) 0.1739 (0.2381) 0.1603 (0.1792) 0.1578 (0.1715) 
Rfreec 0.1479 (0.2148) 0.1985 (0.2628) 0.2333 (0.2949) 0.2171 (0.2429) 0.2116 (0.2393) 
Total unique observations 172514 (17007) 20371 (2005) 15737 (1530) 15141 (1493) 15067 (1486) 
No. of non-hydrogen atoms 3569 1811 1706 1741 1768 
 Protein 3079 1649 1623 1612 1631 
 Ligand 0 14 15 23 17 
 Water 490 148 68 106 120 
rms deviation bonds (Å) 0.006 0.011 0.011 0.011 0.012 
rms deviation angles (°) 0.97 1.20 1.16 1.18 1.05 
Overall mean B-factor (Å2) 13.74 21.80 31.05 28.74 26.68 
Ramachandran plot analysise      
 Favored region 97.94 97.20 95.77 98.54 97.66 
 Allowed region 2.06 2.80 3.29 1.46 2.34 




3.3.1 RibB protein purification and dimer architecture.                                                                               
RibB was heterologously produced in E.coli using a purification protocol with two steps: 
nickel affinity and size exclusion. The protein eluted predominantly as a dimer. The apo-
RibB is dimeric. In presence of substrate and metal, the protein was solved in a higher 
symmetry space group (C2221) with one monomer in asymmetric unit. The protein is still 
dimeric, with a dimer interface in line with a crystallographic 2-fold axis. PISA analysis 
was performed, identifying the dimeric surface interface of 1400 Å2 [29]. Indeed, this is 
indicative that one dimer is composed of two identical, stable monomers without any 
major conformational changes or disorder in protein structure. The RibB monomer has a 
a + b  fold with no recognizable binding motifs. The center of the protein is composed of 
6 b-strands that are surrounded by 9 a-helixes.  Overall 48 residues are involved in 
formation of dimer interface accounting for the third of all amino acid residues in the 
protein. Out of 153 non-bonded contacts, 10 are hydrogen bonds and 2 contacts 
(His137 to Glu175) are salt bridges. The hydrogen bonds originate from an interaction 
between the N-terminal portion of helix 5 (residues 112-123, brown, Figure 3.2) and the 
C-terminal-end of helix 3 (residues 53-62, orange, Figure 3.2) with the loop 175-185 of 
the opposing monomer (green, Figure 3.2). Other hydrophobic interactions come from 
interactions of polypeptide chains originating on the ends of helix 5. N-terminal of helix 5 
there is a span of 26 amino acids that goes through the dimer interface reaching the 
active site on the opposite  
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end of the monomer. A portion of this chain covers the active site and is referred to as 
loop 2 (residues 85-97). C-terminal to helix 5 of the opposing monomer (residues 124-
138, yellow, Figure 3.2). Besides interaction with loop 2, one residue of this chain, 
His137, is buried in the active site of the opposing monomer making a salt bridge with 
Glu175. A nitrogen of the imidazole ring of this side chain is also within hydrogen 
bonding distance of hydroxyls of O1 and O2 of the substrate and has been 
hypothesized to be involved in initial catalytic steps of the mechanism [11]. 
 
3.3.2 Steady state kinetics.                                                                                                   
A steady state kinetic assay was developed based on a previously reported assay that 
measures the formation of terminal ketones. A colorimetric change indicative of this 
moiety is developed in the presence of saturating amounts of creatine and naphthanol 
[30, 31]. This assay was used to determine kinetic parameters when Ru5P, Mg2+ or 
Mn2+ was the varied substrate (Figure 3.3). The turnover numbers for Ru5P and Mg2+ 
are similar with values of 1.50 ± 0.05 min-1 and 1.50 ± 0.03 min-1, respectively. 
Reported, KM values for Ru5P, Mg2+ and Mn2+ are 219 μM, 68 μM and 5.3 μM. The 
value for Ru5P is comparable to the value reported in the literature [12]. However, when 
Mn2+ was substituted for Mg2+, the KM was 13-fold lower (5.3 ± 0.5 μM) and the kcat was 
2-fold higher (2.73 ± 0.03 min-1). This represent the 24-fold increase in the catalytic 
efficiency (360 ± 20 M-1sec-1 for Mg2+ and 8600 ± 800 M-1sec-1 for Mn2+). 
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Figure 3.3. Steady state kinetics. Steady state kinetic parameters with three varied substrates: 











3.3.3 RibB requires one metal in binding and activity.                                             
Historically, it is known that RibB is a Mg-dependent enzyme, but the stoichiometry was 
not discussed. Crystal structures with Zn2+ show two metal ions in the active site 
(Figure 3.6). Metals were titrated against a specific concentration of enzyme (60 μM) 
and activity and metal binding were measured. To ensure no metal is present before the 
start of the titration, enzyme was purified in buffer containing 100 µM EDTA. Therefore, 
assuming EDTA has a stronger binding of metal than RibB, a change in activity is 
expected once the metal binding exceeds 100 µM. 
The titration experiments show that one equivalent of metal binds (Figure 3.4) and is 
required for the activity (Figure 3.5). The activity assay confirms that RibB is inactive in 
the presence of Zn2+ but active in the presence of Mg2+ and Mn2+. One would be 
tempted to propose that additional Mn2+ ions over 1:1 ratio were inhibitory. However, 
after the addition of one equivalent of Mn2+, enzyme precipitation is observed, which is 
one explanation for the decrease in the activity over 160 μM Mn2+ (Figure 3.5). Mn2+ 
has also been previously reported to interfere with the color development in the assay 
[6].  
Here I have reported five structures of the RibB enzyme: apo RibB, RibB with substrate 
bound and no metal, RibB in complex with ribose 5-phosphate and Mn2+ and RibB in 
complex with stereoisomers L-xylulose 5-phosphate and D-xylulose 5-phosphate. 
Orientation of structural elements is very close with RMSD of 0.2 Å (over 201 out of 217 
Ca residues), and in comparison with other Vibrio cholerae RibB structures [12] with 





Figure 3.4. One metal equivalent is binds to RibB. Intrinsic tyrosine fluorescence indicates 
binding of metal to RibB in the ratio of 1:1. 60 μM RibB purified in the presence of 100 μM EDTA 
was titrated with Mg2+ (cyan), Zn2+ (black) and Mn2+ (purple). Fluorescence increases after 100 
μM EDTA concentration has been overcome. There is no significant change in fluorescence 
after an additional 60 μM metal, is added. This concentration is equivalent to the concentration 








Figure 3.5. One metal equivalent is required for RibB activity. Activity of 60 μM RibB in the 
presence of 100 μM EDTA was measured after titration with Mg2+ (cyan), Zn2+ (black) and Mn2+ 
(purple). Activity increases upon addition of 100 μM metal and no longer increases at the 160 








3.3.4 Structural analysis of apo-RibB structure 
The structure of apo-RibB has been solved as a dimer with one dimer in the asymmetric 
unit. Even though this structure has been cryoprotected in the presence of substrate 
and Mg2+ there was no electron density for either one of these. As mentioned 
previously, the active site is composed of two loops, loop 1 (34-41) and loop 2 (85-97) 
located opposite to each other, surrounding the substrate in the active site with loop 1 
orientated away from the protein dimer interface (Figure 3.2). Loop 1 (residues 34-41) 
has been previously reported to be involved substrate and metal recognition and 
binding [10, 12]. This loop is composed of acidic amino acid residues. Out of 8 amino 
acids residues, only 2 residues Arg38 and Asn40 are not acidic and others are equally 
divided between Glu and Asp. In this apo-RibB structure we find loop 1 in the open 
conformation with important Glu39 residues pointing away from the active site (Figure 
3.6). Function of loop 2 based on our structural data is unclear. This loop in known to be 
mobile and well-ordered only in examples of structures with inactive complexes. 
Considering that this is an apo structure it comes as no surprise that loop 2 in both 
monomers was disordered. 
 
3.3.5 Structural analysis of Ru5P (D-ribulose 5-phosphate) RibB structure 
Structure of Ru5P bound to RibB was solved by co-crystallizing the substrate with 
enzyme and soaking 15 molar excess of the substrate prior to cryoprotection. The final 
structure was well ordered with B-factors of 21.8 Å2 for 1.8 Å structure. Both catalytic 
loops in this structure are in closed conformations. Loop 1 is pointed toward the active 




Figure 3.6. Comparison of RibB Ru5P structure, apo-RibB and published structure of 
RibB with Zn2+ (4P8E). Active site is surrounded by two loops. Loop 1 in the closed form 
(brown) coordinates the metal and stabilizes the substrate in active site. Metal is coordinated by 
the substrate and Glu39 and His154. In apo-RibB (cyan) loop 1 is in open conformation (black) 
with Glu39 (cyan) pointing away from active site and plane of imidazole ring of His154 rotated 
by 90 degrees (cyan). While in apo-RibB loop 2 (red) is disordered, in Ru5P it is modelled over 
active site. Also, RibB has usually been modelled with two metals in the active site. Ru5P 
solved structure, shown in green, has been super-imposed with published di-Zn2+ RibB structure 
(PDB:4P8E, gray), Zn2+ ions shown in black spheres. Modeled Ru5P molecules in Zn2+ structure 
(gray) have a different binding pose with a shift of 0.4 Å away from the active site. Zn2+ ions 









comparison to the apo-RibB structure, the closing of the loop 1 also induces the 90 
degrees rotation in the plane of the imidazole ring of His154 (Figure 3.6). The only 
interaction between substrate and loop 2 is weak interaction between Thr94 and 
hydroxyl of O3 (Figure 3.7). 
The residues responsible in the substrate binding in the RibB active site can be divided 
in three sets of residues: 1) Phosphate binding, 2) metal binding and 3) terminal 
hydroxyl binding residues. The residues responsible for binding of the phosphate group 
on the substrate are: Arg38, Arg151 and Thr155. Note that one of these residues Arg38 
belongs to loop 1 defining the importance of this chain in substrate recognition.  Mn2+ is 
coordinated by His154 and Glu39 and the substrate, hydroxyls at carbons C3 and C4 
(O1, O2), phosphate and water molecule hydrogen bonded by other acidic residues of 
loop 1, Asp43 and Glu41 (Figure 3.7). This binding mode we will refer to, from this point 
forward, as first metal binding site. While Ru5P structure was not crystallized in the 
presence of metal this binding site is occupied by a water molecule. On the other side of 
the molecule, the hydroxyl at the carbon C1 is part of hydrogen bonding network formed 
between this hydroxyl, water molecule and three residues Glu175, Cys68, Ser64. The 
hydroxyl is equidistant between GluO2e and Cys68 (3.4 Å). A water molecule, that is 2.4 
Å away from this hydroxyl is also in the center, hydrogen bonding distance away 
between Glu175, Cys68 and Ser64. The water molecule in this network we will refer to 
as W2 in our further discussion. In the analysis of dimer interfaces, we have mentioned 
that polypeptide chain 2 partially intrudes into the active site of the opposing monomer 





Figure 3.7. Active site composition and metal binding. (A) Stereo view representation of 
residues involved in substrate binding in active site. Ribose 5-phospate is shown in blue sticks. 
Substrate is stabilized by phosphate binding (not represented here), Mn2+ residues (residues 
directly involved in binding shown in wheat and indirectly shown in gray) and binding to 
hydroxyls at carbons C1 and C2 (shown in green). Active site has two important water 
molecules. Water molecule in first metal binding site (W1) is bonding distance away from Asp43 
and Glu41. Second water molecule (W2) is binding distance away from hydroxyl at carbon C1 
and Glu175, Ser64 and Cys68. Residues that belong to the catalytically important loop 1 are 
highlighted in brown. Thr94, residue of loop2 (highlighted in red) has a weak hydrogen bonding 
interaction with hydroxyl of carbon C2. His137 (purple) is a residue of opposing monomer 
hydrogen-bonding distance away from hydroxyls at C1 and C2. (B) Detailed stereo-view 
representation of Mn2+ (shown in purple sphere) binding in respective first metal binding pocket. 
Mn2+ metal ion is bound in the octahedral manner electrostatically coordinated by functional 
groups on substrate and on active site residues. Substrate coordinates Mn2+ by hydroxyls at C3 





(Figure 3.7). Also, Ne2 of His137 is equidistant from the hydroxyls of carbon C1 and 
C2.  
In the comparison to the published Ru5P structure with two Zn2+ ions, the substrates 
have a small difference in the binding orientation in the active site with Ru5P from Zn2+ 
shifted by 0.4 Å. This small shift could be attributed to the need to accommodate the 
Zn2+ metal ions in the active site. Furthermore, Zn2+ structure has a second metal 
binding site coordinated by Glu39 and hydroxyls at O2 and O3. This site is also in a 
very electronegative binding pocket surrounded with acidic residues Glu39, Asp41 and 
Glu175 (Figure 3.6).  
 
3.3.6 Structural analysis of R5P (ribose 5-phosphate) RibB structure 
The metal binding is dependent on both the substrate and protein residues. Therefore, 
investigation of the metal binding requires the use of the substrate that has the same 
structural features as Ru5P. Also, this compound had to be inactive with addition of 
metal in order to aid in structure solution. Ribose 5-phosphate (R5P) was a great 
candidate compound, as an aldose sugar to Ru5P it was inactive and structurally similar 
to the substrate.  
The R5P and Ru5P bound RibB structures do not show any significant differences in 
orientation of structural elements, both loops are in closed orientation with RMSD of 
0.134 Å between the two structures. The most noticeable differences are in the active 
site. R5P was solved with one Mn2+ ion in the active site. This metal ion is located in 
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previously proposed first metal binding site. There was no evident electron density in 
the second metal site.   
While the orientation of the Ru5P ligand is similar to R5P, one difference is a rotation of 
the hydroxyl at the position of the carbon C2 by 42 degrees (as measures by dihedral 
angles O2, C2, C3, O3 in Pymol [28]). The most likely explanation is difference in 
carbon hybridization at carbon C2 between two substrates (Figure 3.8, A). 
 
3.3.7 Structural analysis of D-Xy5P (D-xylulose 5-phosphate) RibB structure                      
D-Xy5P is the only Ru5P isomer with significant activity (Figure 3.8, D). In the presence 
of D-Xy5P, VcRibB is 2.6 times less active in comparison to the substrate D-Ru5P. 
Therefore, in the presence of metal, D-Xy5P will make a catalytically active complex. 
This can be used as a justification for the absence of the mobile loop 2. In the active site 
D-Xy5P occupies the same binding cavity as the substrate. Observing along its carbon 
backbone, D-Xy5P is positioned as a mirror image of the substrate. This seems obvious 
as D-Xy5P is an epimer of the substrate at carbon C3. This also means that while 
hydroxyls at carbon C3 are oriented in the same direction, hydroxyl (O3*) and carbon 
C3 of D-Xy5P are moved 1.7 Å away from their respective locations in the substrate. 
Location of O3 of the substrate is now populated with hydroxyl at carbon C4 of D-Xy5P 
(O4*, Figure 3.8, B).  
D-Xy5P has an unprecedented change in the conformation of the Glu39 side chain. 
Over the two states, A and B (Figure 3.8, B), state A (wheat, Figure 3.8, B) is the 




Figure 3.8. Comparison between active site binding and activity of RibB substrate 
isomers. (A) Ribulose 5-phosphate (green) and ribose 5-phosphate (blue) are in similar binding 
orientations in the active site. One difference is the orientation of the hydroxyl (position O2) of 
R5P of 42 degrees (dihedral angle) in comparison to carbonyl of Ru5P. (B) D-Xylulose 5-
phospate (violet) is an epimer of ribulose 5-phosate (green) at carbon C3 leading to distinct 
orientation of hydroxyls (O3 vs O3*). Change in stereochemistry at this hydroxyl at leads to 
movements of hydroxy at O4* to a location occupied by substrate at O3. Also, this structure has 
two distinct orientation of Glu39 side chain. State A (wheat) is identical to Glu39 side chain in 
other structures. State B (pink), in a 72 degrees clockwise rotation of state A side chain. Reason 
behind the rotation could be attributed to hydrogen bonding of side chain to hydroxyls as O3 (C) 
Structure of L-Xy5P (yellow) shows distinct binding orientation in comparison to Ru5P (green). 
As expected by stereochemistry oxygen of carbon C4 in LXy5P(O4*) is rotated away from the 
Mn binding site. Oxygen atoms at position 1 (O1*) and 2 (O2*) are rotated away from their 
binding position closer to Glu 39. This change was sufficient enough to make an additional Mn2+ 
binding site (brown). (D) Bar diagram representation of activity comparison between substrate, 
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D-Ru5P, and isomers. While R5P and L-Xy5P are inactive, D-Xy5P is 2.5 times less active then 

























(pink, Figure 3.8, B) is a rotation of the Glu39A side chain by 72 degrees clockwise. 
According to calculations of occupancy both states occur in equal measures with 51%  
occupancy is in A state and 49% in B state. While reason behind this flip in side chain 
remain unknown, one hypothesis could be related to the hydrogen bonding of Glu39 to 
hydroxyl at O3 (Figure 3.8, B).  In state A (wheat, Figure 3.8, B) side chain of Glu39 is 
oriented in plane with hydroxyls O3 and O4 of the Ru5P with Oe1 being hydrogen 
bonding distance away, 2.5 Å, from O3 and Oe2 binding coordinating the Mn2+. In state 
B (pink, Figure 3.8, B) it appears that the movement of side chain goes in line with the 
location of O3 in D-Xy5P (O3*, Figure 3.8, B). Oe1 of state B is coordinating the Mn2+, 
while Oe2 is weak hydrogen bonding distance away, 3Å, from O3* of D-Xy5P. 
Furthermore, the distance between O3 and O3* is identical to the distance between 
hydrogen bonding oxygen atoms on Glu39 in the two states, of 1.7 Å. This distance is 
identical to the movement of C3* hydroxyl of D-Xy5P. It appears that the movement of 
the C3* of D-Xy5P corelated with the change in Glu39 side chain orientation. This could 
suggest that Glu39 could have more catalytic role rather than only be responsible for 
metal binding. 
D-Xy5P has been refined with a Mn2+ ion in the first metal binding site. Changes in the 
orientation of the O3 and O4 hydroxyls cause coordination changes to Mn2+ in D-Xy5P. 
Mn2+ in now coordinated only with hydroxyl at O4 and phosphate because O3* is too far 
away from the metal ion to be considered a valid coordination ligand, 3.7 Å. This makes 
Mn2+ directly coordinated to 5 ligands instead of 6 ligands in octahedral manner as 
previously described. It is important to note that we have found some electron density 
suggestive of a water molecule at the position of O4 which would be a sixth ligand of the 
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metal coordination shell. However, during the refinement process that electron density 
disappeared which is suggestive of a very low occupancy of that water molecule and it 
is a reason why it was not modeled in the structure.  
 
3.3.8 Structural analysis of L-Xy5P (L-xylulose 5-phosphate) RibB structure 
L-Xy5P bound structure, in comparison, has significant changes in ligand orientation. In 
truth, this was to be expected as L-Xy5P differs from the substrate in stereochemistry at 
carbons C3 and C4. In the active site, the change of the stereochemistry at C4 changes 
the orientation of the hydroxyl of L-Xy5P: instead of being coordinated to Mn2+ ion, this 
moiety is within hydrogen bonding distance of Cys68. Due to orientation of L-Xy5P 
ligands are close to the first Mn2+ metal center with average ligand distance of 2.15 Å. 
Metal ion is now being coordinated by oxygens on carbon C2 and C3 and by the 
phosphate which is pushed away from the phosphate binding pocket by 0.7 Å. Changes 
in the coordination of Mn2+ have also drastic changes in the orientation of the atoms at 
the C1 end of L-Xy5P. In comparison to the substrate binding, the hydroxyl at carbon 
C1 has been rotated and moves 3.5 Å closer to Glu39 residue (Figure 3.8, D). This shift 
was enough to make a convenient electrostatic binding pocket for binding of another 
Mn2+ ion. This Mn2+ binding site, matches the location of second metal binding site 
previously reported. 
 
3.3.9 EPR investigation of Mn2+ binding                                                                                
Di-nuclear Mn2+ centers have been previously investigated by EPR in the dinitrogenase 
reductase enzyme [32]. According to this study, EPR spectra of di-nuclear Mn2+ have 
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characteristic features at 2800G and 3800G with hyperfine splitting of 45G. A high 
intensity six peak pattern at 3400G is suggestive of free Mn2+ metal ions in solution [32]. 
Following the similar methodology, we should be able to distinguish a two Mn2+ ion 
interaction at a specific point of time in the catalyzed reaction. First, in order to inspect 
Mn2+ binding in RibB an equimolar concentration of enzyme and Mn2+ (3mM) were 
mixed with substrate Ru5P (2mM) and reactions left to proceed for 1 min, 10 min and 
60 min before freezing (Figure 3.9, A). Absence of hyperfine splitting in these spectra 
indicate absence of di-nuclear Mn2+ in excess of metal during the catalytic reaction. 
Moreover, subsequent decrease in intensity of six peaks at 3400G upon addition of 
enzyme and substrate is suggestive of metal binding within the enzyme. Second, 
structural data of L-Xy5P (Figure 3.8, C) provided direct evidence of VcRibB structure 
with di-nuclear Mn2+ metal ions separated by 4 Å. Using L-Xy5P in EPR studies 
provided a control experiment for Mn2+ binding in the enzyme active site. As expected, 
EPR studies are suggestive of di-nuclear Mn2+ center both in presence of metal excess 
(dark purple, Figure 3.9, C) after 10 min and equimolar solution after 10 sec (hyperfine 
splitting of 46G and 2800G). Lastly, lowering the ratio of Mn2+ and freezing the reaction 
mixture (in presence of Ru5P) within 10 sec lead to an ERP spectra indicative of di-
nuclear Mn2+ center, predominant in the equimolar solution (Figure 3.9, B). These 
results would suggest that in the beginning of the reaction di metal center can bind in 
the active site. However, as hyperfine splitting is absent in samples with excess metal 
(dark blue, Figure 3.9, B) in later time point, it can be concluded that di-nuclear Mn2+ is 







Figure 3.9. Examination of RibB catalyzed reaction using perpendicular-mode EPR 
spectroscopy. Free Mn2+ in solution exhibits a characteristic six-line signal centered at 3400G. 
The features at 2800G and 3800G with hyperfine splitting of 45G are suggestive a dinuclear 
Mn2+ species. (A) RibB reaction in presence of excess Mn2+ left to react for period of 1, 10 and 
60 min and quenched by freezing the reaction in an EPR tube with liquid nitrogen. Decrease of 
intensity in the peak associated with free Mn2+ in solution is observed upon addition of enzyme 
and substrate, which is suggestive of metal binding within the enzyme. (B) Lowering the ratio of 
Mn2+ and quenching the reaction in shorter period of time (10sec) leads to similar hyperfine 
splitting, suggestive of a dinuclear Mn2+ center. This feature, however, disappears in presence 
of excess Mn2+ and extending the reaction to 20sec (dark blue line). (C) Substitution of D-Ru5P 
for L-Xy5P in presence of excess of Mn2+ (dark purple, 10min) leads to characteristic dinuclear 
Mn2+ features (hyperfine splitting = 46G). Equimolar solution of reaction components after 10sec 







                                               
4 Data acquired by Melissa C. Denler, graduate student in Dr Timothy A. Jackson lab. Melissa 




The RibB enzyme in the riboflavin biosynthesis is structurally and functionally unique. 
Functionally this enzyme is magnesium dependent and catalyzes a reaction that 
abstracts carbon C4 of the substrate ribulose 5-phospate and removes the hydroxyl on 
carbon C1 to make a final product (Figure 3.1). Structurally, the topology of this enzyme 
is unparalleled and no other enzyme with similar chemistry has been documented. 
Structural data of RibB enzymes with Mn2+, Zn2+, Ca2+ have been presented as a 
paradigm that enzyme catalysis required two metals for full activity. However, no further 
stoichiometric evidence demonstrating this was presented. Here, we show steady state 
kinetics of the RibB enzyme in the presence of Mn2+ as well as crystal structures of apo-
RibB, RibB in complex with inactive analogue, ribose 5-phosphate with one Mn2+, 
stereoisomers L-xylulose 5-phosphate with two Mn2+ metal ions, D-xylulose 5-
phosphate with one Mn2+ and structure of RibB with substrate ribulose 5-phosphate with 
no metal. Furthermore, we present binding, activity assay and EPR evidence that one 
metal binding site is required for the full enzyme activity. 
Use of Mn2+ as a replacement for Mg2+ ions in magnesium depended protein is a 
common methodology [33, 34]. In enzyme complexes, both Mn2+ and Mg2+ ions have 
typical 6 coordinate geometry with magnesium ions having much higher probability of 
formation of hexahydrate complexes. Both are considered to be hard acids as breaking 
of their hexacoordinate shell requires significant thermodynamic contribution [34]. Their 
ionic radii is also very similar with reported values of 0.65 Å for magnesium and 0.74 Å 
for manganese [34]. Mn2+ ions have a big advantage when used as replacement to 
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Mg2+ ions in crystal structure studies. While Mg ions are isoelectronic with water and 
cannot be readily distinguished based on the electron density, Mn2+ is a transition metal 
with greater electron density. Use of Ca2+ or Zn2+ in these studies could be problematic 
due to differences in physical properties of these metals and metal of interest, Mg2+. 
Ca2+ ion is also a hard acid, but the ionic radius is larger than Mg2+ (0.99 Å). Also, Ca2+ 
ions have been described to have coordination geometries of 6 or 8. Enzymatic sites 
made for Ca2+ ion are usually designed by enzymes that sequester it and readily bind to 
it, such as EF hand motif [34]. Zinc is different than either magnesium, manganese or 
calcium. While its ionic radius is similar to magnesium and manganese (0.71 Å), zinc 
like calcium, easily interchanges between different coordination states (coordination 
number of 4,5 or 6). As such zinc is not as strong of a Lewis acid which has been 
proposed as one of the reason for RibB inactivity with this metal [11]. Finally, Mn2+ is 
EPR active which provides better opportunities to study metal binding and coordination 
chemistry.  
Use of Mn2+ as a metal of choice in RibB enzyme kinetics was beneficial. In comparison 
to Mg2+, the efficiency of the enzyme in the presence of Mn2+ was 24 times higher 
(Figure 3.3). Chemically this could be explained by ligand preferences between these 
metals. Mg2+ has greater preference for oxygen ligands (hydroxyls, carboxylic acids) 
and is not commonly seen in complex with nitrogen ligands which is not true for Mn2+ 
complexes. In nature, enzymes have been shown to use this method to discriminate 
between Mg2+ or Mn2+ metal ion binding [33, 34].  It is clear however, based on the 
crystal structures, that the first binding site has a nitrogen binding ligand from His154 
(Figure 3.7, B). This could explain the kinetics and stronger association between Mn2+ 
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the lower KM and the active site ligands allowing for better stabilization of substrate in 
the active site and more efficient steady state kinetic profile (Figure 3.3). Nevertheless, 
RibB is most likely a magnesium-dependent enzyme. Because the availability of Mn2+ in 
the cell is low in comparison to Mg2+ [35] the likelihood of Mn2+ association with RibB in 
the cell is unlikely.  
Earlier we have described two metal titration experiments that demonstrate that RibB 
binds one metal and requires one metal in the catalysis. Our structure of the inactive 
substrate, aldose sugar analogue, ribose 5-phosphate, supports that location of this 
metal site is in the first metal site coordinated by His154, Glu39 and the substrate. It is 
important to note that both ribose 5-phosphate and ribulose 5-phosphate have same 
orientation in the active site with no changes in protein structure or residue orientation 
(Figure 3.8). The previously determined structure of RibB with glycerol supports our 
hypothesis. Glycerol in this structure is oriented in same way as carbohydrate backbone 
of the substrate and a single Mn2+ is in the same orientation as in our structures 
(PDB:1K40) [11].  
Proposed second metal binding site in the literature is coordinated by Glu39 and 
hydroxyls O3 and O2 of the substrate (Figure 3.6). Considering that other chelating 
ligands on this metal are water molecules this would suggest that this site is labile and 
might not have a catalytic purpose in the enzyme. The region of second metal binding is 




Figure 3.10. RibB active site binding cavity. Active site of the RibB occupies surface area of 
237 Å2 and volume of 95 Å3 (generated by CASTp 3.0 [36]). In the closed conformation of active 
site loops substrate binding is buried deep in the pocket between two monomers. First metal 
binding site (purple) is coordinated by the protein and the substrate. In contrary proposed 
second metal binding site is open to the solvent allowing the diffusion of the metal between 
solvent and this ligand-rich binding environment. (A) Surfaces binding area of VcRibB structure 
with Zn2+ (PDB:4P8E). (B) Structure of VcRibB with R5P  
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Glu175, Asp43) making an ideal electrostatic area to attract the metal ions (Figure 
3.10). Therefore, it is not surprising that in excess of metal ions this area of the active 
site can be a preferred binding area for the metal. As we have shown with the structure 
of the non-catalytic L-Xy5P, the proximity of the substrate hydroxyls (O1* and O2*, 
Figure 3.8, C) are brought closer to the Glu39 locking binding metal in place. EPR data 
does show some evidence of weak di-metal presence in first few seconds of the 
catalyzed reaction. As these features are absent in later stages of catalyzed reaction in 
presence of excess of metal, dinuclear Mn2+ center is not required for catalysis.  
The evidence indicates a single metal binding site in VcRibB, at the location of first 
metal binding site. We therefore conclude that during catalysis, one metal is required 
near the C4 portion of the substrate. This doesn’t necessarily eliminate the currently 
proposed mechanism of 1,2 methyl shift but certainly opens up possibilities for a new 
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Identification of intermediates in 3,4-dihydroxy-2-butanone 4-phosphate synthase 
(RibB) of riboflavin biosynthesis 
 
4.1 INTRODUCTION 
The RibB enzyme converts a molecule of the five-carbon sugar ribulose 5-phosphate 
into a four-carbon compound 3,4-dihydoxy-2 butanone 4-phosphate by removal of 
carbon C4 of the substrate as formate. The consensus in the literature is a 1,2-methyl 
shift mechanism, a model that has been related to mechanisms of D-xylose isomerase 
[1, 2], D-ribulose 5-phosphate isomerase [3, 4]) and 1-deoxy-D-xylulose 5-phosphate 
(DXP) reductoisomerase from terpenoid biosynthesis [5]). This mechanism involves 
generation of the intermediate in which methyl group is shifted to the neighboring 
carbon with high partial positive charge, such as carbon of the carbonyl (Figure 4.1). 
Implementation of this skeletal rearrangement in the reaction mechanism of RibB and 
DXP reductoisomerase are summarized in Figure 4.1. In the example of the DXP 
reductoisomerase, the methyl shifted is the carbon C1 (Figure 4.1, A, red). In RibB, this 
carbon is equivalent to phosphorylated carbon C5 of the substrate (Figure 4.1, B, red). 
For the DXP reductoisomerases an alternative mechanism, called fragmentation 
mechanism, has been proposed [5]. Unlike the canonical mechanism, this model 
involves the generation of the b-hydroxy ketone intermediate (Figure 4.1). This ketone 




Figure 4.1. Examples of proposed enzymatic mechanisms, canonical (1,2-methyl shift) vs 
fragmentation (retro-aldol) mechanism. (A) Proposed enzymatic pathways for 1-deoxy-D-
xylulose 5-phosphate (DXP) reductosiomerase (B) Proposed enzymatic pathways for RibB 
catalyzed reaction.  While chemical logic of fragmentation and canonical mechanism is similar in 










b-hydroxy is broken to generate two fragment pieces. A potential conformation change 
in one of the fragments and acid-base chemistry results in the fragments being rejoined 
to make a new intermediate.   
The evidence supporting the canonical mechanism over the fragmentation mechanism 
is scarce. First argument supporting 1,2-methyl shift is based on isotopically labeled 
feeding studies. In these experiments, based in enzymes from terpenoid biosynthesis, 
stochiometric ratios of labeled fragments were measured during the catalyzed reaction. 
As fragments were not detected during the reaction, this led to the conclusion that 
fragmentation mechanism is improbable. Nevertheless, the design of the experiment 
assumed that the substrate fragments are released during catalysis [6]. In the case of 
RibB, evidence supporting the canonical mechanism is based on end point assays, 
disregarding that fragments are enzyme intermediates and can only be detected on a 
much shorter time scale [7-9]. In addition, Cleland and colleagues provided evidence for 
a fragmentation mechanism in ribulose 5-phosphate isomerase using kinetic isotope 
effects, in which a change in the rate constants is observed when atoms in a substrate 
are replaced by heavy isotopes [4]. Therefore, due to limited and inconclusive evidence, 
it is valuable to investigate the fragmentation mechanism in the RibB reaction.  
The two proposed mechanisms for RibB are shown in Figure 4.2. In order to distinguish 
between these mechanisms, we will focus on identifying the pivotal intermediates in 
each proposed model. For example, in the fragmentation mechanism, a key step would 




Figure 4.2. Proposed mechanisms for RibB reaction. Both proposed pathways start with 
molecule of Ru5P in the same manner (black arrows) by dehydration, removal of the hydroxyl at 
the carbon C1 (red dot) to make intermediate 1, 2-hydroxy-3,4-dioxopentyl phosphate (green 
box). Intermediate 1 can make product, DHBP via fragmentation mechanism (blue arrows) or 
canonical mechanism (red arrows). In upcoming experiments identification of crucial 
intermediates (red boxes) will help us discern between two mechanisms. Fragmentation 
mechanism leads to the formation of two fragments: enediolate of hydroxyacetone and 2-
phosphoglycolic acid (pink box). In further discussion we will refer to 2-phosphoglycolic acid 











blue arrow, Figure 4.2). Conversely, one would look for the formation of the 1,2-methyl 
shift product in support of the canonical mechanism (red box, red arrow, Figure 4.2). 
Here, I report evidence, using 13C NMR and X-ray crystallography, that the mechanism 
of the RibB reaction might indeed follow a fragmentation mechanism model.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1 VcRibB purification.                                                                                                    
The protein was purified as described in chapter 3. For purposes of the NMR 
experiment, in the last step of the purification the enzyme was exchanged into 25mM 
Tris:HCl pH 8.0, 10% glycerol.  
 
4.2.2 6-phosphogluconate dehydrogenase (Ec6PGDH) purification.                         
Purification of 6-phosphogluconate dehydrogenase from E.Coli (Ec6PGDH) was done 
as previously described [10]. The gene sequence from E.Coli K-12 (ATCC #47076) was 
synthesized and placed into a pET-28b(+) vector using NdeI and HindIII restriction sites 
(stop codon placed after HindIII 3’ end) by Genscript. This overexpression construct 
yields a construct with N-terminal His tag. The purification protocol is similar to the RibB 
protein purification with a few changes. During cell growth, cells were induced with 1 
mM IPTG (isopropyl β-D-1-thiogalactopyranoside) and further incubated at 20 oC 
overnight while shaking (220 RPM). Protein was separated out by Nickel Supedex fast 
flow (GE Healthcare), eluting at 300 mM imidazole, as determined by SDS-PAGE. The 
fractions containing the Ec6PGDH were dialyzed into 25 mM Tris:HCl pH 8.0 with two 
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buffer changes at 8 hours and 12 hours. The protein was concentrated and stored for 
later use at -80 oC. The final yield of the protein was 185 mg per liter of culture.  
 
4.2.3 Preparation of 13C labeled ribulose 5-phosphate.                                              
Ribulose 5-phosphate was prepared by reconstitution of the pentose phosphate 
pathway following the previously published protocol [11]. In first vial of 4 ml, 50 mM 
Tris:HCl pH7.5, 30 mM of ATP, 30 mM of unifomly labeled 13C glucose (Cambridge 
Isotope Laboratories) and 10 mM DTT (GoldBio) were added and the pH was adjusted 
to 7.5 using 1M NaOH. 60U of hexokinase (Sigma Aldrich, Saccharomyces cervisiae) 
was added and the solution incubated at 37 oC for 30 min. In a second vial of 4 ml, 50 
mM Tris:HCl pH 7.5, 10 mM of NADPH, 50 mM of a-ketoglutarate and 75 mM of 
ammonium chloride were added and the pH was adjusted to 7.5 with 1N NaOH. The 
two vials were combined and 0.5 mg/ml final concentration of Ec6PGDH, 20 U of 
glutamate dehydrogenase (Sigma Aldrich, bovine liver) and 12 U of glucose 6-
phosphate dehydrogenase (Sigma Aldrich, Saccharomyces cervisiae) were added. The 
reaction was incubated at room temperature overnight. Barium chloride, at a final 
concentration of 50 mM, was added to the solution, mixed and incubated at room 
temperature for 5 min. A white precipitate formed and was pelleted by centrifuging the 
solution in a swing bucket rotor centrifuge for 20 min at 3100 x g (4 oC). The white 
precipitate was resuspended in ethanol and incubated at -20 oC for 4 hours. The 
precipitate was washed in 90% ethanol three times and dried over anhydrous calcium 
chloride in vacuo. The dried white solid was resuspended in 30 ml of water and 50mM 
final concentration of barium sulfate was added. The white precipitate was removed by 
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centrifugation for 20 min, 3100 x g at 4 oC. The supernatant was lyophilized producing a 
white powder that was resuspended in 50 mM Tris:HCl pH 7.5. The concentration of 
Ru5P was determined by colorimetric assay [12] and standard curve using D-Ru5P 
(Sigma Aldrich) as previously described. The Ru5P was authenticated by 13C NMR 
using previously published peak assignments [9]. 
 
4.2.4 Single-turnover NMR experiments.                                                                              
RibB in 50mM Tris:HCl, 10% glycerol pH 8.0 was concentrated to 111 mg/ml (4.3 mM). 
The reaction mixture contained 50 mM Tris:HCl pH 7.5, 20% D2O, 2 mM 13C Ru5P and 
2.8 mM enzyme in 700 μL final volume at 4 oC. The reaction was initiated by addition of 
enzyme and was quenched with 70 μl of 4 M H2SO4 at allocated time points. The 
reaction mixture was stored in -20 oC until NMR data acquisition. NMR data were 
collected using a Brucker AVIII 500MHz NMR equipped with cryogenically-cooled 
carbon observe probe. The 13C NMR spectra were obtained after 1200 scans, at 25 oC, 
over 40 min per experiment. Spectra preliminarily referenced based on published 
spectra peaks5 [9].  
 
4.2.5 VcRibB crystallization with intermediate 1 and Mn2+.   
Purified protein at 32.9 mg/ml was mixed with 15 times molar excess of D-ribulose-5-
phosphate in 50 mM Tris-HCl pH 7.5 (Sigma Aldrich) and incubated on ice for 15 min. 
Protein was crystallized using the hanging-drop vapor diffusion method. Each drop (3 
                                               
5 NMR data acquired with help from Justin T. Douglas and Sarah A. Neuenswander. Support for 
the NMR instrumentation was provided by NIH Shared Instrumentation Grant # S10RR024664 
and NSF Major Research Instrumentation Award # 1625923 
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μl) was prepared by mixing protein and precipitant solution in equal amounts. The 
precipitant protein solution was 0.1 M Lithium Acetate and 16% PEG 3350. In 
preparation for data collection, rod shaped crystals were first soaked in precipitant 
solution mixed with a final concentration of 40 mM D-ribulose 5-phosphate overnight 
then soaked in cryoprotect containing precipitant supplemented with 30% ethylene 
glycol and 4mM MnCl2 for 3 min.  
4.2.6 VcRibB crystallization with intermediate 2 and Mn2+.                                            
Purified protein at 32.9 mg/ml was mixed with 15 times molar excess of D-ribulose-5-
phosphate in 50 mM Tris-HCl pH 7.5 (Sigma Aldrich) and incubated on ice for 15 min. 
Protein was crystallized using the hanging-drop vapor diffusion method. Each drop (3 
μl) was prepared by mixing protein and precipitant solution in equal amounts. The 
precipitant protein solution was 0.1 M Lithium Acetate and 16% PEG 3350. In 
preparation for data collection, rod shaped crystals were first soaked in precipitant 
solution mixed with a final concentration of 40 mM D-ribulose 5-phosphate overnight 
then soaked in cryoprotect containing precipitant supplemented with 30% ethylene 
glycol and 4mM MnCl2 for 70 min.  
4.2.7 X-ray diffraction data collection.                                                                              
Data for both intermediate crystal variants were collected at the Stanford Synchrotron 
Radiation Laboratory (SSRL, Stanford, CA) [13] beamline 12-2 using a wavelength of 
0.9795 Å at 100 K. The software package Blu-Ice [14] was used to collect 1200 
oscillation images (0.15 ° per image) with an exposure time of 0.2 sec.  
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4.2.8 X-ray diffraction data collection and processing for RibB intermediate 1 structure 
with Mn2+ 
Diffraction data were collected using a beam size of 100 μm x 60 μm with transmission 
set to 9.5% and a detector distance of 366.4mm. Diffraction data were processed using 
XDS [15] to 2.2 Å in the space group C 2 2 21 with cell dimensions of a=60.34 Å, 
b=78.56 Å, c=90.54 Å, a = β = g =90.0°. A phasing solution was obtained via molecular 
replacement using PHENIX, Phaser-MR [16] with 4P8E(PDBID) [17] monomer as a 
model. The model was prepared by removing all water molecules, hydrogens and any 
previously modeled substrates. The search procedure was set to look for one copy of 
the model in an asymmetric unit and all possible space group enantiomers. One 
molecular replacement solution was identified with an LLG of 3268 and a TFZ of 41. 
The solution was subjected to alternating cycles of model building and refinement using 
Coot [18] and Phenix.Refine [19, 20]. Water molecules were added automatically and 
inspected manually using Coot. Intermediate 1 and manganese ion were added 
manually. Restraints for intermediate 1 were generated using eLBOW [21] and REEL 















                                               
6 Rmerge = Σh|Ih - <I>|/ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of 
all symmetry-related reflections bRcryst = Σ||Fo| - |Fc||/Σ|Fo|, Fo and Fc are observed and calculated 
structure factor amplitudes. cFive percent of the reflections were initially reserved to create an 
Rfree test set used during each subsequent round of refinement.   
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4.2.9 X-ray diffraction data collection and processing for RibB intermediate 2 structure 
with Mn2+ 
Diffraction data were collected using a beam size of 100 μm x 60 μm with transmission 
set to 11.0% and a detector distance of 404.0 mm. Diffraction data were processed 
using XDS [15] to 2.1 Å in the space group C 2 2 21 with cell dimensions of a=60.91 Å, 
b=78.99 Å, c=90.37 Å, a = β = g =90.0°. A phasing solution was obtained via molecular 
replacement using PHENIX, Phaser-MR [16] with 4P8E(PDBID) [17] monomer as a 
model. The model was prepared by removing all water molecules, hydrogens and any 
previously modeled substrate. The search procedure was set to look for one copy of the 
model in an asymmetric unit and all possible space group enantiomers. One molecular 
replacement solution was identified with an LLG of 3098 and a TFZ of 44.0. The 
solution was subjected to alternating cycles of model building and refinement using 
Coot [18] and Phenix.Refine [19, 20]. Water molecules were added automatically and 
inspected manually using Coot. Intermediate 2 and manganese ions were added 
manually. Restraints for intermediate 2 were generated using eLBOW [21] and REEL 
[22]. Statistics for data refinement and analysis can be found in Table 4.1. 
 
4.2.10 Intermediate 1 crystallographic model.                                                                      
The final model has one monomer in the asymmetric unit with residues 2 to 217 fully 
resolved. The final model contained 53 water molecules and an intermediate 1, one 
Mn2+ ion in the active site and two molecule of ethylene glycol. Ramachandran analysis 
was calculated with MolProbity [23] with 98.13%  in the allowed regions and no outliers. 
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4.2.11 Intermediate 2 crystallographic model.  
The final model has one monomer in the asymmetric unit with residues 3 to 217 fully 
resolved. The final model contained 68 water molecules and one intermediate 2 and two 
Mn2+ ions in the active site. Ramachandran analysis was calculated with MolProbity [23] 
showing 97.06% in the favored regions and 0.49% of outliers. Asp214 was the outlier 




4.3.1 Structure of RibB intermediate 1 and consequences on catalysis 
RibB crystals were grown in presence of substrate and subsequently soaked into MnCl2 
cryoprotectant solution. Structure refinement led to the generation of electron density 
that by our analysis corresponds to one of the first intermediates of the RibB catalytic 
cycle. In the first attempt to model the correct substrate we used the ribulose 5-
phosphate substrate. After subsequent rounds of structure refinement and modeling, 
negative electron density indicated the absence of a portion of the molecule at the 
carbon C1. As the first step in RibB mechanism (green box, Figure 4.2) using 
intermediate 1 as an alternative modeling compound was justified. Indeed, modelling of 
intermediate 1 (2-hydroxy-3,4-dioxopentyl phosphate) in the active site of RibB provided 
a model with acceptable crystallographic statistics. After refinement, electron density of 
simulated annealing composite omit map had electron density of the substrate set at 1.5 
sigma with B-factors of 42.24 Å2.  
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In comparison to the model of substrate binding presented in chapter 3, significant 
changes in the substrate binding and metal coordination can be observed. As described 
in chapter 3, metal is coordinated by Glu39, His154, a water molecule (hydrogen 
bonded to Asp34), and to the substrate by the phosphate and hydroxyls O4 and O3. 
Additionally, the hydroxyl O1 is 3.4 Å away from Cys68 and Glu175. Intermediate 1 
binding is more elongated in comparison to the substrate. The hydroxyl at O1 has been 
removed as a water molecule during dehydration reaction, therefore the position in the 
protein structure is now occupied by the hydroxyl of O2. Like its predecessor, the 
hydroxyl at O2 is hydrogen bonded to Cys68 and Glu175 (Figure 4.3). On the other end 
of the molecule, at the metal binding site, this ‘elongation’ leads to displacement of the 
hydroxyl at O3 form the Mn2+ coordination sphere and the changing of O4 coordination 
from equatorial to axial position. The original O4 location in the substrate structure has 
been replace by a water molecule (W2, Figure 4.3) that is 1.9 Å away from Mn2+ metal 
center. The intermediate 1 structure was determined with one metal ion in the active site 
with no density for a second metal ion. Therefore, this structural data can be used as 
further evidence for a single metal requirement for the enzyme binding and catalysis 
(Chapter 3).  
 
4.3.2 Generation of the intermediate 2 
Prolonged soaking of Ru5P containing crystals with MnCl2 lead to a RibB crystal 




Figure 4.3. Detailed proposed mechanism of intermediate 1 formation. (A) Active site 
overview of R5P (blue) and intermediate 1 (green) binding. Note the changes in the coordination 
ligands of Mn2+. In R5P structure Mn2+ is coordinated with oxygens O3, O4 and phosphate from 
the substrate, Glu39, His154 and water molecule (W1). With removal of hydroxyl (at O1) only 
hydroxyl at O4 and phosphate are coordinating the metal. Previous placement of O4 is now 
populated with the water molecule (W2) preserving octahedral geometry of Mn2+. (B) Previous 
research and bonding distance of Glu175 and Cys68 would suggest that these residues have 




Upon inspection this electron density accommodates two Mn2+ ions and two carbon 
compound with the phosphate moiety. The only compound in either reaction mechanism 
that could satisfy these characteristics would be 2-phosphoglycolic acid, one of the 
fragments in the fragmentation model. Indeed, after refinement we have generated the 
simulated annealing composite omit map set to 2 sigma confirming successful 
compound modeling (Figure 4.4, B).   
Unlike the already presented RibB structures, the structure with intermediate 2 had a 
disordered loop (residues 87-95). The absence of this loop could indicate a major 
conformational change in the active site during catalysis. Furthermore, modeling of 2-
phosphoglycolic acid in the active site raises the important question of the location of 
other fragmentation piece, the enediolate. Absence of loop 2 and the enediolate 
fragment lead us to the hypothesis that loop 2 might be involved in stabilization of this 
fragment during the catalysis. In its ordered state, as we can see in the intermediate 1 
structure, loop 2 sits above the location where the enediol fragment would reside.  
The intermediate 2 structure also has two Mn2+ ions in the active site. The location of 
the first Mn2+ is identical to the first metal binding site of the substrate and intermediate 
1 (Chapter 3). The second metal binding site is coordinated by the Glu39, the 
carboxylic acid of the fragment and 4 water molecules. The presence of the second 
metal in active site could be attributed to absence of loop 2. Moreover, coordination to 
extensive number of water molecule could suggest that this metal binding is factitious, 
frequently exchanging with the solvent, which contain excess Mn2+. Location of the 




Figure 4.4. Simulated annealing composite omit map of RibB structures with 
intermediates. (A) Active site modeled with the intermediate 1 (green box), structure has one 
Mn2+ ion with map set to 1.5 sigma. (B) Site modeled with the 2-phosphoglycolic acid, one of 
two fragments in the fragmentation mechanism, map set to 2.0 sigma. Unlike in (A) this 
structure has disordered loop 2 (residues 87-96) and it has an additional Mn2+ binding in the 













structure (Figure 3.6). This data can be used as another form of evidence for frequency 
of metal binding in the second binding site (Figure 3.8). 
 
4.3.3 Single turnover NMR supports structural data 
Uniformly 13C labeled Ru5P was used as a substrate for single turnover experiments 
with RibB purified in 10% glycerol at 4 degrees. At specific time points the reactions 
were quenched with acid and analyzed using 13C NMR. The synthesis of the 13C labeled 
substrate, generated using pentose phosphate pathway enzymes as described in 
methods, and product formation by RibB were confirmed by comparison to previously 
published peak assignments [9]. The most prominent peaks in the spectrum are the 
peaks associated with carbon C2 ((t), 212ppm) represented by a purple dot in Figure 
4.5, and the formate product peak ((s), 171 ppm), represented by a blue dot in Figure 
4.5. As it has been previously reported, we have also observed that assignment and 
peak intensity of peaks at carbon C3 and C5 were dependent on percent of D2O 
available in the solution. Peaks at other carbons can only be seen if the D2O 
concentration is less than 5% [9].  
With timepoints to five minutes, we did not observe the formation of the formate peak. 
Instead we saw appearance of an intermediate 1, in the range of 212 ppm. A peak 
assigned as a triplet peak corresponds to carbon C2, Figure 4.5. Over the course of 5 
minutes, this peak is shifted by 0.7 ppm upfield with intervening quartets as intermediate 
is formed. The generation of this new triplet peak is due to removal of the hydroxyl at 



















Figure 4.6. Single turnover NMR provides additional evidence of fragmentation 
mechanism. RibB catalyzed reaction in NMR tube, under single turnover conditions in 
presence of VcRibB in 10% glycerol at 4oC with acid quench. (A) Data shows the appearance of 
doublet after 60 sec in the two proposed reaction mechanisms. Only the possible intermediate 
with this NMR profile would be Intermediate 2. (B) Also, the dehydration reaction at the carbon 





(Figure 4.6). Based on the chemical properties we know that this peak has an adjacent 
carbon atom with carboxy group or equivalent (150 ppm or higher). Therefore, this 
doublet represents the 2-phoshoglycolic intermediate from the fragmentation 




RibB catalyzes the removal of the carbon C4 of the substrate Ru5P as formate to make 
the DHBP product. There are competing models that have been described for the 
related enzymes such as DXP reductoisomerase enzyme in terpene biosynthesis [5, 
19],  and  isomerase enzymes such as D-ribulose 5-phosphate isomerase [3, 4] or D-
xylose isomerase[1, 2]. These models include a skeletal rearrangement model 
(mechanism involving 1,2-methyl shift) and a fragmentation model (fragment generation 
after retro-aldol reaction). These enzymes all catalyze a reaction on a structurally similar 
substrate. The substrates DXP and ribulose 5-phosphate differ in functional groups on 
C1 and the stereochemistry at C3, while D-Ru5P and D-Xy5P are epimers at carbon 
C3. However, the reactions catalyzed by all of these enzymes are different. While RibB 
reactions catalyzes the metal-dependent removal of formate, the reductoisomerases 
perform an NADPH assisted reduction of the intermediate in the final step, and the 
isomerases catalyze change of the stereochemistry of the substrate. Nevertheless, the 
skeletal rearrangement or canonical mechanism has been established in the literature 
as the model that describes the RibB catalysis. Structural and NMR data we present 
here shows the presence of 2-hydroxy-3,4-dioxopentyl phosphate (green box, Figure 
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4.2) and a 2-phosphoglycolate intermediates (pink box, Figure 4.2). Evidence provided 
suggests that fragmentation mechanism, not canonical mechanism is most probable 
mechanism followed by RibB.  
Intermediate 1, 2-hydroxy-3,4-dioxopentyl phosphate, is the last common intermediate 
between the two proposed models (Figure 4.2). The structure of RibB with bound 
intermediate 1 identifies residues that are involved in the dehydration of the substrate at 
carbon C1 (red dot, Figure 4.2). Involvement of Glu175 and Cys68 has been previously 
discussed [24]. According to this mechanism, Liao et al. suggest these two residues 
(Glu174, Cys66) are involved in initial enolization and dehydration step of 1,2 skeletal 
rearrangement mechanism. Furthermore, this mechanism suggested that the imidazole 
side chain of opposing monomer, His136 (identical to His 137, Chapter 3), is used as a 
proton donor during the enolization step of the reaction. However, extensive 
mutagenesis studies on RibB active site residues suggest that any change to Glu39 or 
Glu175 completely abolished the activity of the enzyme. Also, mutation of Cys68 or 
His137 to serine lead to decrease in enzyme activity by 3 and 7 times, respectively [25, 
26]. Here we provide an alternative method for formation of intermediate 1 (Figure 4.3). 
Catalysis starts with Glu175 abstracting a proton from carbon C3, 2.6 Å away. The loss 
of the proton promotes enolization and elimination of water generated at C1 with a 
proton donated by Cys68. In last two steps Glu175 and Cys68 are regenerated to make 
intermediate 1 (Figure 4.3). It is interesting to note that in the next step of the 
mechanism a water molecule is required for the hydroxylation at the carbon C4 (Figure 
4.2). A water molecule (W2) in evident in intermediate 1 structure (Figure 4.3) located 
ideally beside the carbon C4. If the next step in the mechanism is hydration of C4, it 
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comes as no surprise that water W2 is coordinated to the Mn2+. This provides additional 
evidence for the fragmentation mechanism, since hydration occurs after the skeletal 
rearrangement in the canonical mechanism. After hydration at carbon C4 the 
fragmentation mechanism proposes formation of a b-hydroxy ketone intermediate that, 
after retro-aldol reaction, produces two fragments. We have visualized one of the 
fragments, 2-phosphoglycolic acid, in the crystal structure. The single turnover 13C NMR 
corroborate this hypothesis with the appearance of a doublet at 166ppm. In accordance 
with the fragmentation mechanism, the next step in the reaction would require the 
nucleophilic attack by carbon C5 (yellow, Figure 4.2) to join the fragments. However, in 
the binding pose in the structure, phosphoglycolate is oriented in catalytically non-
covalent conformation. This would indicate that this fragment will have to go through 
conformational change or repositioning in order for reaction to proceed, which could be 
the results of the catalytically irrelevant Mn2+ ion altering the binding mode as concluded 
by the disordered loop.  
We have presented considerable evidence that indicate a new mechanism is required to 
describe the chemistry of the RibB enzyme. We are currently optimizing the NMR 
experiment to identify all the intermediates in real time (not using quenching 
experiments). We are also derivatizing the 2-phosphoglycolic acid intermediate for 
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In bacterial cells, formate can be recycled and reused by one-carbon metabolism or 
treated as a byproduct of primary metabolic pathways. In one-carbon metabolism, a 
folate cofactor, N10-formyl-THF, is used to transport a formyl group and incorporate it 
into purine metabolism, protein synthesis, and biosynthesis of secondary metabolites. 
Enzymes that facilitate incorporation of formate from folate cofactors are known as 
transformylases. Here, I describe structural and functional studies of two formate-
utilizing enzymes: PvdF, a new class of transformylase from Pseudomonas aeruginosa, 
and RibB enzyme from riboflavin biosynthesis.   
 
5.1.1 AICAR and GAR transformylases.  
AICAR transformylases and GART are prime examples of the utilization of the folate 
cofactor N10-formyl-THF in the incorporation of one carbon unit into a variety of 
metabolites. In chapter 1, I have outlined differences between these two enzymes 
classes. Also, I provide examples of other kinds of GART-like enzymes and their 
function in protein synthesis (MTF) [1, 2], N-sugar transformylation [3], and in NRPS 
peptide assembly [4]. It is very evident that all of these enzymes share a common 
transformylase fold that is responsible for the movement of formate from the folate 
cofactor to the substrate. In all of these enzymes, the N-terminal domain “additions” are 
structurally different but serve a common purpose to stabilize and orient the substrate 
before the formylation occurs. It was therefore suggested these enzymes are distantly 
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related through gene transfer [4]. AICAR are significantly different from GART enzymes. 
These transformylases can only be found as part of nucleotide biosynthesis and follow a 
transformylation mechanism that is distinct from GART enzymes. These enzymes also 
do not share any structural resemblance as AICAR transformylases have a different fold 
and are part of larger two domain proteins.  
 
5.1.2 PvdF hydroxyornithine transformylase from P.aeruginosa. 
Iron acquisition is important for virulence in Pseudomonas aeruginosa, an opportunistic, 
ESKAPE pathogen. Secretion of siderophores is one method to obtain iron that is 
necessary for bacterial survival in an iron-limiting environment [5-7]. In the mixed-type 
siderophore pyoverdin, iron is chelated in an octahedral manner with two hydroxamate 
groups from fOHOrn and catecholate of the chromophore. In chapter 2, I explored 
structural and functional characteristics of the enzyme responsible for hydroxamate 
group formation in pyoverdin, PvdF. Here I have demonstrated that PvdF catalyzes the 
formate group transfer from N10 -formyl-THF analogue to the substrate. Structurally, 
however, PvdF has several long insertions that together account for over 100 of the 275 
amino acids that we hypothesize are responsible for the substrate and cofactor 
stabilization. As these elements are not present in any other transformylase, PvdF 
represents a unique class of transformylase enzyme. In the future, it would be 
interesting to see if our hypothesis on function of structural insertions is correct. This 
can be further investigated in PvdF structural studies. Structure of PvdF with substrate 
and cofactor bound in the active site can elucidate more not just about structural 
insertions but also about enzyme mechanism. PvdF can now also be used as model to 
 140 
solve other hydroxyornithine transformylases such as Rft from rhodochelin biosynthesis 
and CchA from coelichelin biosynthesis [8]. The knowledge gained in the study of PvdF, 
its unique structural and functional features, can be an important next step toward better 
rational drug design, especially considering the wealth of antifolate inhibitors at our 
disposal.   
 
5.1.3 3,4-dihydroxy-2-butanone 4-phosphate synthase (RibB) of riboflavin biosynthesis. 
In mammals, riboflavin, or vitamin B2, serves numerous functions. In one of them 
riboflavin is utilized as the main precursor to FAD and FMN, cofactors in the electron 
transport chain [9-14]. Unfortunately, mammals cannot synthesize this vitamin and have 
to obtain it through external sources. Plants, bacteria and lower eukaryotes do 
synthesize riboflavin. This is the reason why further elucidation of enzymes in the 
riboflavin biosynthetic pathway can be used as potential antibacterial or antimicrobial 
targets [15-17].  In this study, we investigated a fascinating reaction catalyzed by the 
enzyme RibB, a rate-limiting enzyme in riboflavin biosynthesis. Literature and research 
presented over the past couple of decades described RibB as a magnesium-dependent 
enzyme that required two metal centers for catalysis. Consensus in the literature also 
states that the probable enzyme mechanism follows 1,2 methyl-shift, a skeletal 
rearrangement mechanism that facilitates carbon C4 removal by making a new carbon-
carbon bond between carbon C3 and C5 of Ru5P [18-22]. Evidence shown in these 
studies are contrary to results I present in chapters 3 and 4. Instead of two metals, RibB 
binds one metal and requires only one metal for catalysis. Stoichiometry evidence, 
using activity and binding studies, EPR, and structural data clearly indicate that the 
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RibB catalytic cycle requires one metal for the activity by a reaction mechanism that is 
distinctly dissimilar to a 1,2-methyl shift (Chapter 3). This new mechanism, referred to 
as a fragmentation mechanism, yields two fragments of Ru5P during catalysis. One of 
these fragments, 2-phosphoglycolic acid, was captured during single turnover NMR 
studies as well as in the crystal structure.  Positioning of this intermediate in the crystal 
structure does not provide any further clues on the next catalytic step of the reaction. 
This could mean that a significant change in the orientation of the fragment is necessary 
for further catalysis. Also, the absence of a second enediolate fragment and disordered 
loop 2 might suggest a potential function of this loop (Chapter 4). This enigma could be 
resolved with a crystal structure with both fragment intermediates bound, SAR by NMR, 
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